BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494-500. [PMID: 8559202 DOI: 10.1056/nejm199602223340803] [Cited by in Crossref: 2024] [Cited by in F6Publishing: 347] [Article Influence: 81.0] [Reference Citation Analysis]
Number Citing Articles
1 Peter P, George A. Posterior reversible encephalopathy syndrome and the pediatric population. J Pediatr Neurosci 2012;7:136-8. [PMID: 23248696 DOI: 10.4103/1817-1745.102579] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
2 Elhassan M, Saidahmed O, Adebayo A, Archibald N. Persistent Cortical Blindness Following Posterior Reversible Encephalopathy Syndrome (PRES) as a Complication of COVID-19 Pneumonia. Cureus 2021;13:e12794. [PMID: 33500867 DOI: 10.7759/cureus.12794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Hammer ES, Cipolla MJ. Cerebrovascular Dysfunction in Preeclamptic Pregnancies. Curr Hypertens Rep 2015;17:64. [PMID: 26126779 DOI: 10.1007/s11906-015-0575-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 8.6] [Reference Citation Analysis]
4 El Maalouf G, Mitry E, Lacout A, Lièvre A, Rougier P. Isolated brainstem involvement in posterior reversible leukoencephalopathy induced by bevacizumab. J Neurol 2008;255:295-6. [PMID: 18283405 DOI: 10.1007/s00415-008-0692-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
5 McKinney AM, Sarikaya B, Gustafson C, Truwit CL. Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2012;33:896-903. [PMID: 22241378 DOI: 10.3174/ajnr.A2886] [Cited by in Crossref: 79] [Cited by in F6Publishing: 26] [Article Influence: 8.8] [Reference Citation Analysis]
6 Raman R, Devaramane R, Jagadish GM, Chowdaiah S. Various Imaging Manifestations of Posterior Reversible Encephalopathy Syndrome (PRES) on Magnetic Resonance Imaging (MRI). Pol J Radiol 2017;82:64-70. [PMID: 28243339 DOI: 10.12659/PJR.899960] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Wang W, Zhao LR, Lin XQ, Feng F. Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer. World J Gastroenterol. 2014;20:6691-6697. [PMID: 24914397 DOI: 10.3748/wjg.v20.i21.6691] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
8 Chou MC, Lee CY, Chao SC. Temporary Visual Loss Due to Posterior Reversible Encephalopathy Syndrome in the Case of an End-Stage Renal Disease Patient. Neuroophthalmology 2018;42:35-9. [PMID: 29467807 DOI: 10.1080/01658107.2017.1322109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Kaneda H, Okamoto I, Satoh T, Nakagawa K. Reversible posterior leukoencephalopathy syndrome and trastuzumab. Invest New Drugs 2012;30:1766-7. [PMID: 21633924 DOI: 10.1007/s10637-011-9696-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
10 Chawla R, Smith D, Marik PE. Near fatal posterior reversible encephalopathy syndrome complicating chronic liver failure and treated by induced hypothermia and dialysis: a case report. J Med Case Rep. 2009;3:6623. [PMID: 19830117 DOI: 10.1186/1752-1947-3-6623] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
11 Lee VH, Temes RE, John S, Conners JJ, Bleck T, Prabhakaran S. Posterior reversible leukoencephalopathy syndrome presenting with global cerebral edema and herniation. Neurocrit Care 2013;18:81-3. [PMID: 23184269 DOI: 10.1007/s12028-012-9798-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Mandal SK, Sagar G, Sahoo M, Jasuja S. Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis. Indian J Nephrol 2012;22:130-2. [PMID: 22787316 DOI: 10.4103/0971-4065.97134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 van Beers EJ, Stam J, van den Bergh WM. Licorice consumption as a cause of posterior reversible encephalopathy syndrome: a case report. Crit Care 2011;15:R64. [PMID: 21332974 DOI: 10.1186/cc10040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
14 Saley T, Barton A, Sood SB, Thukaram R. Posterior Reversible Encephalopathy Syndrome Complicating Ruptured Appendicitis and Abscess Drainage in a Previously Healthy Pediatric Patient. J Pediatr Intensive Care 2019;8:92-5. [PMID: 31093461 DOI: 10.1055/s-0038-1668603] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Dowling MR, Li S, Dey BR, McAfee SL, Hock HR, Spitzer TR, Chen YB, Ballen KK. Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact. Bone Marrow Transplant 2018;53:199-206. [PMID: 29131150 DOI: 10.1038/bmt.2017.239] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
16 Schweitzer AD, Parikh NS, Askin G, Nemade A, Lyo J, Karimi S, Knobel A, Navi BB, Young RJ, Gupta A. Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome. Neuroradiology 2017;59:379-86. [PMID: 28289809 DOI: 10.1007/s00234-017-1815-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 10.5] [Reference Citation Analysis]
17 Raz N, Levin N. Cortical and white matter mapping in the visual system-more than meets the eye: on the importance of functional imaging to understand visual system pathologies. Front Integr Neurosci 2014;8:68. [PMID: 25221482 DOI: 10.3389/fnint.2014.00068] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
18 Saner FH, Nadalin S, Radtke A, Sotiropoulos GC, Kaiser GM, Paul A. Liver transplantation and neurological side effects. Metab Brain Dis. 2009;24:183-187. [PMID: 19139982 DOI: 10.1007/s11011-008-9119-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
19 Chaiworapongsa T, Romero R, Korzeniewski SJ, Cortez JM, Pappas A, Tarca AL, Chaemsaithong P, Dong Z, Yeo L, Hassan SS. Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. J Matern Fetal Neonatal Med 2014;27:132-44. [PMID: 23687930 DOI: 10.3109/14767058.2013.806905] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
20 Gerretsen P, Kern RZ. Reversible cerebral vasoconstriction syndrome: a thunderclap headache-associated condition. Curr Neurol Neurosci Rep 2009;9:108-14. [PMID: 19268033 DOI: 10.1007/s11910-009-0018-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
21 Friedrich MG. Interplay of cardiac and cognitive function: how much do we really understand? J Am Heart Assoc 2015;4:e001685. [PMID: 25628409 DOI: 10.1161/JAHA.114.001685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Princiotta Cariddi L, Tabaee Damavandi P, Carimati F, Banfi P, Clemenzi A, Marelli M, Giorgianni A, Vinacci G, Mauri M, Versino M. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient. J Neurol 2020;267:3157-60. [PMID: 32583053 DOI: 10.1007/s00415-020-10001-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 31.0] [Reference Citation Analysis]
23 Ait S, Gilbert T, Cotton F, Bonnefoy M. Cortical blindness and posterior reversible encephalopathy syndrome in an older patient. BMJ Case Rep 2012;2012:bcr0920114782. [PMID: 22669215 DOI: 10.1136/bcr.09.2011.4782] [Reference Citation Analysis]
24 Lindå H, von Heijne A. A case of posterior reversible encephalopathy syndrome associated with gilenya(®) (fingolimod) treatment for multiple sclerosis. Front Neurol 2015;6:39. [PMID: 25788891 DOI: 10.3389/fneur.2015.00039] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
25 Magsi S, Zafar A. Malignant Posterior Reversible Encephalopathy Syndrome-An Exacting Challenge for Neurocritical Care Physicians. Neurohospitalist 2017;7:196-9. [PMID: 28974999 DOI: 10.1177/1941874416688989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Andreux F, Marro B, El Khoury N, Seilhean D, Alamowitch S. Reversible encephalopathy associated with cholesterol embolism syndrome: magnetic resonance imaging and pathological findings. J Neurol Neurosurg Psychiatry 2007;78:180-2. [PMID: 17229746 DOI: 10.1136/jnnp.2006.099770] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
27 Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J 2001;77:24-8. [PMID: 11123390 DOI: 10.1136/pmj.77.903.24] [Cited by in Crossref: 156] [Cited by in F6Publishing: 88] [Article Influence: 7.8] [Reference Citation Analysis]
28 Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29:1036-1042. [PMID: 18356474 DOI: 10.3174/ajnr.a0928] [Cited by in Crossref: 632] [Cited by in F6Publishing: 135] [Article Influence: 48.6] [Reference Citation Analysis]
29 Godasi R, Rupareliya C, Bollu PC. Bilateral Occipital Lobe Hemorrhages Presenting as Denial of Blindness in Posterior Reversible Encephalopathy Syndrome- A Rare Combination of Anton Syndrome and Encephalopathy. Cureus 2017;9:e1746. [PMID: 29218261 DOI: 10.7759/cureus.1746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Sasson SC, Oon A, Chagantri J, Brew BJ, Carr A. Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report. BMC Infect Dis 2013;13:396. [PMID: 23981526 DOI: 10.1186/1471-2334-13-396] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
31 Rivillas JA, Galindo-Coral S, Arias-Mora F, Lopez-Ponce de Leon JD, Florez-Alarcón NA, Olaya-Rojas P, Gomez-Mesa JE. Posterior Reversible Encephalopathy Syndrome Associated with Tacrolimus in Cardiac Transplantation. Case Rep Cardiol 2021;2021:9998205. [PMID: 34258073 DOI: 10.1155/2021/9998205] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ou S, Xia L, Wang L, Xia L, Zhou Q, Pan S. Posterior Reversible Encephalopathy Syndrome With Isolated Involving Infratentorial Structures. Front Neurol 2018;9:843. [PMID: 30356684 DOI: 10.3389/fneur.2018.00843] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
33 Parikh NS, Schweitzer AD, Young RJ, Giambrone AE, Lyo J, Karimi S, Knobel A, Gupta A, Navi BB. Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome. J Neurol Sci 2017;380:11-5. [PMID: 28870548 DOI: 10.1016/j.jns.2017.06.044] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
34 Colombo A, Martinelli Boneschi F, Beretta S, Bresolin N, Versino M, Lorusso L, Spagnoli D, Nastasi G, Vallauri D, Rota S, Repaci M, Ferrarini M, Pozzato M, Princiotta Cariddi L, Tabaee Damavandi P, Carimati F, Banfi P, Clemenzi A, Marelli M, Giorgianni A, Vinacci G, Mauri M, Melzi P, Di Stefano M, Tetto A, Canesi M, Salmaggi A. Posterior reversible encephalopathy syndrome and COVID-19: A series of 6 cases from Lombardy, Italy. eNeurologicalSci 2021;22:100306. [PMID: 33490654 DOI: 10.1016/j.ensci.2020.100306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
35 Chelis L, Souftas V, Amarantidis K, Xenidis N, Chamalidou E, Dimopoulos P, Michailidis P, Christakidis E, Prassopoulos P, Kakolyris S. Reversible posterior leukoencephalopathy syndrome induced by pazopanib. BMC Cancer 2012;12:489. [PMID: 23088634 DOI: 10.1186/1471-2407-12-489] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
36 Davidson BA, Secord AA. Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer. Int J Womens Health 2014;6:289-300. [PMID: 24648773 DOI: 10.2147/IJWH.S49781] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
37 Rota E, Vallisa D, Morelli N, Scagnelli P. Iatrogenic Coagulopathy and the Development of Posterior Reversible Encephalopathy Syndrome after L-asparaginase Chemotherapy. J Clin Imaging Sci 2016;6:7. [PMID: 27014503 DOI: 10.4103/2156-7514.177553] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
38 Alexander S, David VG, Varughese S, Tamilarasi V, Jacob CK. Posterior reversible encephalopathy syndrome in a renal allograft recipient: A complication of immunosuppression? Indian J Nephrol 2013;23:137-9. [PMID: 23716922 DOI: 10.4103/0971-4065.109439] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
39 Ali WH. Ciprofloxacin-associated posterior reversible encephalopathy. BMJ Case Rep 2013;2013:bcr2013008636. [PMID: 23585504 DOI: 10.1136/bcr-2013-008636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
40 Kim MU, Kim SY, Son SM, Park YH. A case of tacrolimus-induced encephalopathy after kidney transplantation. Korean J Pediatr 2011;54:40-4. [PMID: 21359060 DOI: 10.3345/kjp.2011.54.1.40] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
41 Aygün BK, Baykuş Y, Berilgen S, Kavak B, Celik H, Gürateş B. Posterior Reversible Encephalopathy Syndrome in severe preeclampsia: case report and literature review. J Turk Ger Gynecol Assoc 2010;11:216-9. [PMID: 24591940 DOI: 10.5152/jtgga.2010.41] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
42 Weiss ZF, Rich J, Wing EJ. Posterior reversible encephalopathy syndrome in a patient with HIV/AIDS and immune reconstitution syndrome: a case study and literature review. Oxf Med Case Reports 2018;2018:omy046. [PMID: 30151215 DOI: 10.1093/omcr/omy046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
43 Hammad T, DeDent A, Algahtani R, Alastal Y, Elmer L, Medhkour A, Safi F, Assaly R. Posterior Reversible Encephalopathy Syndrome Secondary to CSF Leak and Intracranial Hypotension: A Case Report and Literature Review. Case Rep Neurol Med 2015;2015:538523. [PMID: 26106495 DOI: 10.1155/2015/538523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
44 Apuri S, Carlin K, Bass E, Nguyen PT, Greene JN. Tacrolimus associated posterior reversible encephalopathy syndrome - a case series and review. Mediterr J Hematol Infect Dis 2014;6:e2014014. [PMID: 24678391 DOI: 10.4084/MJHID.2014.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
45 Straathof K, Anoop P, Allwood Z, Silva J, Nikolajeva O, Chiesa R, Veys P, Amrolia PJ, Rao K. Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2017;52:159-62. [PMID: 27643866 DOI: 10.1038/bmt.2016.232] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
46 Grelat M, Debaux JB, Sautreaux JL. Posterior reversible encephalopathy syndrome after depletive lumbar puncture: a case report. J Med Case Rep 2014;8:261. [PMID: 25063365 DOI: 10.1186/1752-1947-8-261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
47 Ramakrishnan S, Kannan B, Kannan A, Venkatesan EP. Vision Loss in Guillain-Barre Syndrome: Is it a Complication of Guillain-Barre Syndrome or Just a Coincidence? J Ophthalmic Vis Res 2016;11:340-1. [PMID: 27621799 DOI: 10.4103/2008-322X.188405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
48 Shah R, Kubisz-Pudelko A, Reid J. Posterior reversible encephalopathy syndrome following an inadvertent dural puncture during an emergency laparotomy for ischemic colitis - a case report. Local Reg Anesth 2014;7:1-4. [PMID: 24600245 DOI: 10.2147/LRA.S57660] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
49 Servillo G, Bifulco F, De Robertis E, Piazza O, Striano P, Tortora F, Striano S, Tufano R. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med. 2007;33:230-236. [PMID: 17119920 DOI: 10.1007/s00134-006-0459-0] [Cited by in Crossref: 112] [Cited by in F6Publishing: 57] [Article Influence: 7.5] [Reference Citation Analysis]
50 Hodzic E, Brcic M, Atic M, Halilcevic A, Jasarevic A, Aleckovic-Halilovic M, Trojak D, Atic N, Zulic S, Mehmedovic Z, Iveljic I. Posterior Reversible Encephalopathy Syndrome (PRES) as a Complication of Immunosuppressive Therapy in Renal Transplantation in Children. Med Arch 2014;68:218-20. [PMID: 25568539 DOI: 10.5455/medarh.2014.68.218-220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
51 Wijeratne T, Wijeratne C, Karimi L, Sales C, Crewther SG. Case Report: Posterior Reversible Leukoencephalopathy Syndrome (PRES) as a Biologically Predictable Neurological Association in Severe COVID-19. First Reported Case From Australia and Review of Internationally Published Cases. Front Neurol 2020;11:600544. [PMID: 33584499 DOI: 10.3389/fneur.2020.600544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Zhang W, Egashira N, Masuda S. Recent Topics on The Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities. Int J Mol Sci 2019;20:E3210. [PMID: 31261959 DOI: 10.3390/ijms20133210] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
53 Castillo A, Payne JD, Nugent K. Posterior reversible leukoencephalopathy syndrome after kratom ingestion. Proc (Bayl Univ Med Cent) 2017;30:355-7. [PMID: 28670086 DOI: 10.1080/08998280.2017.11929647] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
54 Hinduja A. Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome. Front Neurol 2020;11:71. [PMID: 32117030 DOI: 10.3389/fneur.2020.00071] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 30.0] [Reference Citation Analysis]
55 Pacheva IH, Ivanov IS, Stefanova K, Chepisheva E, Chochkova L, Grozeva D, Stoyanova A, Milenkov S, Stefanova P, Petrova A. Central Nervous System Involvement in Henoch-Schonlein Purpura in Children and Adolescents. Case Rep Pediatr 2017;2017:5483543. [PMID: 28316855 DOI: 10.1155/2017/5483543] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
56 Hossain MA, Jehangir W, Nai Q, Jessani N, Khan R, Yousif A, Sen S. Posterior Reversible Encephalopathy Syndrome in a Bone Marrow Transplant Patient: A Complication of Immunosuppressive Drugs? World J Oncol 2015;6:426-8. [PMID: 28983342 DOI: 10.14740/wjon932w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
57 Castello-Branco RC, Cerqueira-Silva T, Andrade AL, Gonçalves BMM, Pereira CB, Felix IF, Santos LSB, Porto LM, Marques MEL, Catto MB, Oliveira MA, de Sousa PRSP, Muiños PJR, Maia RM, Schnitman S, Oliveira-Filho J. Association Between Risk of Obstructive Sleep Apnea and Cerebrovascular Reactivity in Stroke Patients. J Am Heart Assoc 2020;9:e015313. [PMID: 32164495 DOI: 10.1161/JAHA.119.015313] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
58 Tchaou M, Modruz N, Agoda-Koussema LK, Michelot A, Naffa S, Jeudy V, Kaczmarek R. Two Unusual Aspects of Posterior Reversible Encephalopathy Syndrome Mimicking Primary and Secondary Brain Tumor Lesions. Case Rep Radiol 2015;2015:456217. [PMID: 26587304 DOI: 10.1155/2015/456217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
59 Zou LP, Liu LY, Li H, Wang YY, Liu Y, Chen J, Hu LY, Liu MJ, Zhang MN, Lu Q, Ma SF. Establishment and utility assessment of posterior reversible encephalopathy syndrome early warning scoring (PEWS) scale establishment and utility assessment of PEWS scale. BMC Neurol 2019;19:30. [PMID: 30791893 DOI: 10.1186/s12883-019-1247-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
60 Imaizumi T, Kawasaki Y, Matsuura H, Matsumoto A, Takano K, Suyama K, Hashimoto K, Suzuki H, Hosoya M. Efficacy of steroid pulse, plasmapheresis, and mizoribine in a patient with focal segmental glomerulosclerosis. Pediatr Nephrol 2007;22:1215-8. [PMID: 17347835 DOI: 10.1007/s00467-007-0461-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
61 Jayaweera JL, Withana MR, Dalpatadu CK, Beligaswatta CD, Rajapakse T, Jayasinghe S, Chang T. Cyclophosphamide-induced posterior reversible encephalopathy syndrome (PRES): a case report. J Med Case Rep. 2014;8:442. [PMID: 25519913 DOI: 10.1186/1752-1947-8-442] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
62 Foerster R, Welzel T, Debus J, Gruellich C, Jaeger D, Potthoff K. Posterior reversible leukoencephalopathy syndrome associated with pazopanib. Case Rep Oncol 2013;6:204-8. [PMID: 23626562 DOI: 10.1159/000350742] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
63 Squair JW, Phillips AA, Harmon M, Krassioukov AV. Emergency management of autonomic dysreflexia with neurologic complications. CMAJ 2016;188:1100-3. [PMID: 27221275 DOI: 10.1503/cmaj.151311] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
64 Ortiz GA, Bianchi NA, Tiede MP, Bhatia RG. Posterior reversible encephalopathy syndrome after intravenous caffeine for post-lumbar puncture headaches. AJNR Am J Neuroradiol 2009;30:586-7. [PMID: 18945799 DOI: 10.3174/ajnr.A1321] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
65 Karumanchi SA, Lindheimer MD. Advances in the understanding of eclampsia. Curr Hypertens Rep 2008;10:305-12. [PMID: 18625161 DOI: 10.1007/s11906-008-0057-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
66 Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis 2013;20:229-39. [PMID: 23928387 DOI: 10.1053/j.ackd.2013.01.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
67 Pavlidou E, Pavlou E, Anastasiou A, Pana Z, Tsotoulidou V, Kinali M, Hatzipantelis E. Posterior reversible encephalopathy syndrome after intrathecal methotrexate infusion: a case report and literature update. Quant Imaging Med Surg 2016;6:605-11. [PMID: 27942481 DOI: 10.21037/qims.2016.10.07] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
68 Shaban A, Leira EC. Neurological Complications in Patients with Systemic Lupus Erythematosus. Curr Neurol Neurosci Rep 2019;19:97. [PMID: 31773306 DOI: 10.1007/s11910-019-1012-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
69 Wagner SJ, Acquah LA, Lindell EP, Craici IM, Wingo MT, Rose CH, White WM, August P, Garovic VD. Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control. Mayo Clin Proc 2011;86:851-6. [PMID: 21878596 DOI: 10.4065/mcp.2011.0090] [Cited by in Crossref: 70] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
70 Chandramohan V, Nagarajan VP, Sathyamoorthi MS, Kumar S, Shanmugasundaram C, Periakaruppan G, Scott JX. Posterior reversible encephalopathy syndrome in a child with autoimmune lymphoproliferative syndrome: Case report and review of literature. J Pediatr Neurosci 2012;7:221-4. [PMID: 23560015 DOI: 10.4103/1817-1745.106486] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
71 Zama D, Masetti R, Cordelli DM, Vendemini F, Giordano L, Milito G, Franzoni E, Porta F, Prete A, Rondelli R, Pession A. Risk factor analysis of posterior reversible encephalopathy syndrome after allogeneic hematopoietic SCT in children. Bone Marrow Transplant 2014;49:1538-40. [PMID: 25133894 DOI: 10.1038/bmt.2014.182] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
72 Marrone LC, Marrone BF, de la Puerta Raya J, Gadonski G, da Costa JC. Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome. Case Rep Oncol 2011;4:82-7. [PMID: 21475595 DOI: 10.1159/000324581] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
73 O'Kane M, Elhalwagy H, Kumar S, Badawi C. Unusual presentation of PRES in the postnatal period. BMJ Case Rep 2014;2014:bcr2013203406. [PMID: 25008333 DOI: 10.1136/bcr-2013-203406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
74 Malik MT, Majeed MF, Zand R. Serotonin Syndrome Presenting as a Posterior Reversible Encephalopathy Syndrome. Case Rep Neurol 2020;12:63-8. [PMID: 32231545 DOI: 10.1159/000505907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
75 Farouk SS, Rein JL. The Many Faces of Calcineurin Inhibitor Toxicity-What the FK? Adv Chronic Kidney Dis 2020;27:56-66. [PMID: 32147003 DOI: 10.1053/j.ackd.2019.08.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 18.0] [Reference Citation Analysis]
76 Omer TA, Doherty C. Posterior reversible encephalopathy syndrome (PRES) complicating the 'legal high' mephedrone. BMJ Case Rep 2011;2011:bcr0220113904. [PMID: 22689272 DOI: 10.1136/bcr.02.2011.3904] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
77 Ramirez R, Muskula PR, Everley MP. Posterior Reversible Encephalopathy Syndrome After Orthotopic Heart Transplantation: A Case Report. Am J Case Rep 2017;18:487-90. [PMID: 28465499 DOI: 10.12659/ajcr.903403] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
78 Kastrup O, Gerwig M, Frings M, Diener HC. Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns. J Neurol 2012;259:1383-9. [PMID: 22189837 DOI: 10.1007/s00415-011-6362-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
79 Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol. 2008;29:924-930. [PMID: 18272559 DOI: 10.3174/ajnr.a0960] [Cited by in Crossref: 128] [Cited by in F6Publishing: 29] [Article Influence: 9.8] [Reference Citation Analysis]
80 Sarala Kumari D, Arumilli MN, Siva Kumar Reddy L, Reddy DN, Motor R. Acute Intermittent Porphyria Presenting with Posterior Reversible Encephalopathy Syndrome: A Rare Cause of Abdominal Pain and Seizures. Indian J Crit Care Med 2020;24:724-6. [PMID: 33024385 DOI: 10.5005/jp-journals-10071-23532] [Reference Citation Analysis]
81 Marrone LC, Martins WA, Brunelli JP, Fussiger H, Carvalhal GF, Filho JR, Soder RB, Schuck M, Viola FS, Marrone AC, da Costa JC. PRES with asymptomatic spinal cord involvement. Is this scenario more common than we know? Spinal Cord Ser Cases 2016;2:15001. [PMID: 28053726 DOI: 10.1038/scsandc.2015.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
82 Liu B, Zhang X, Zhang FC, Yao Y, Zhou RZ, Xin MM, Wang LQ. Posterior reversible encephalopathy syndrome could be an underestimated variant of "reversible neurological deficits" in Systemic Lupus Erythematosus. BMC Neurol 2012;12:152. [PMID: 23217201 DOI: 10.1186/1471-2377-12-152] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
83 Zaki SA, Chavan V, Shanbag P. Unusual presentation of Takayasu's arteritis as posterior reversible encephalopathy syndrome. Ann Indian Acad Neurol 2011;14:214-6. [PMID: 22028540 DOI: 10.4103/0972-2327.85900] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
84 Rahal AK, Truong PV, Kallail KJ. Oxaliplatin-Induced Tonic-Clonic Seizures. Case Rep Oncol Med 2015;2015:879217. [PMID: 26491586 DOI: 10.1155/2015/879217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
85 Aulakh P, Fatakhov E, Koch CF Jr, Kapil S. Posterior reversible encephalopathy syndrome with documented hyponatraemia. BMJ Case Rep 2013;2013:bcr2013009311. [PMID: 23904416 DOI: 10.1136/bcr-2013-009311] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
86 Largeau B, Le Tilly O, Sautenet B, Salmon Gandonnière C, Barin-Le Guellec C, Ehrmann S. Arginine Vasopressin and Posterior Reversible Encephalopathy Syndrome Pathophysiology: the Missing Link? Mol Neurobiol 2019;56:6792-806. [PMID: 30924075 DOI: 10.1007/s12035-019-1553-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
87 Hadj JO, Braven RD, Tillier C, Schrijver HM, Verheul HM, VAN DER Vliet HJ. Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinoma. Oncol Lett 2012;3:1293-6. [PMID: 22783436 DOI: 10.3892/ol.2012.646] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
88 Ettinger N, Pearson M, Lamb FS, Wellons JC 3rd. Pediatric posterior reversible encephalopathy syndrome presenting with isolated cerebellar edema and obstructive hydrocephalus. J Neurosurg Pediatr 2014;14:344-7. [PMID: 25062302 DOI: 10.3171/2014.6.PEDS13553] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
89 Benoist G, Dossier C, Elmaleh M, Dauger S. Posterior reversible encephalopathy syndrome revealing renal artery stenosis in a child. BMJ Case Rep 2013;2013:bcr2013010110. [PMID: 23975912 DOI: 10.1136/bcr-2013-010110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
90 Saran S, Bansal P, Singhal S, Malik A. Coexisting cerebral venous sinus thrombosis and posterior reversible encephalopathy syndrome in a preeclamptic female. Ann Afr Med 2018;17:94-5. [PMID: 29536965 DOI: 10.4103/aam.aam_41_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
91 Singh RR, Ozyilmaz N, Waller S, U-King-Im JM, Lim M, Siddiqui A, Sinha MD. A study on clinical and radiological features and outcome in patients with posterior reversible encephalopathy syndrome (PRES). Eur J Pediatr 2014;173:1225-31. [PMID: 24737291 DOI: 10.1007/s00431-014-2301-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
92 Jeon JS, Park SP, Seo JG. Posterior reversible encephalopathy syndrome due to hyponatremia. J Epilepsy Res 2014;4:31-3. [PMID: 24977130 DOI: 10.14581/jer.14008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
93 Dos Reis Simões da Silva FM, Burgos Pêgo PM, Henriques Vendrell MC, de Azevedo Batalha Ferreira Dos Santos Farias MJ, Ribeiro Timóteo ÂC, Martins da Costa MC, Monteiro Barbosa Moreira Cravo IM, Ribeiro Gomes FM. Posterior Reversible Encephalopathy Syndrome and Anti-Angiogenic Agents: A Case Report. Neuroophthalmology 2011;35:32-7. [PMID: 27956931 DOI: 10.3109/01658107.2010.539763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
94 Medani S, Short S, Wall C. Nurofen Plus toxicity-what should nephrologists be alert to? Rare complications of an increasingly misused medication. NDT Plus 2010;3:343-5. [PMID: 25949426 DOI: 10.1093/ndtplus/sfq079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
95 Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, Matharu KS, Karumanchi SA, D'Amore PA. VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. J Exp Med 2008;205:491-501. [PMID: 18268040 DOI: 10.1084/jem.20072041] [Cited by in Crossref: 122] [Cited by in F6Publishing: 95] [Article Influence: 9.4] [Reference Citation Analysis]
96 Alparslan M, Bora U, Hüseyin K, Ayhan D, Gültekin S. Posterior reversible encephalopathy syndrome in a renal transplanted patient. Am J Case Rep 2013;14:241-4. [PMID: 23861991 DOI: 10.12659/AJCR.889260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
97 How J, Blattner M, Fowler S, Wang-Gillam A, Schindler SE. Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature. Neurologist 2016;21:112-7. [PMID: 27801773 DOI: 10.1097/NRL.0000000000000105] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
98 Hawfield A, Freedman BI. Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection. Ther Adv Cardiovasc Dis 2009;3:65-73. [PMID: 19124387 DOI: 10.1177/1753944708097114] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
99 Adam G, Ferrier M, Patsoura S, Gramada R, Meluchova Z, Cazzola V, Darcourt J, Cognard C, Viguier A, Bonneville F. Magnetic resonance imaging of arterial stroke mimics: a pictorial review. Insights Imaging 2018;9:815-31. [PMID: 29934921 DOI: 10.1007/s13244-018-0637-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
100 Shepard PW, St Louis EK. Seizure treatment in transplant patients. Curr Treat Options Neurol. 2012;14:332-347. [PMID: 22660960 DOI: 10.1007/s11940-012-0180-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
101 Li H, Liu Y, Chen J, Tan X, Ye XY, Ma MS, Huang JP, Zou LP. Posterior reversible encephalopathy syndrome in patients with hematologic tumor confers worse outcome. World J Pediatr 2015;11:245-9. [PMID: 26041496 DOI: 10.1007/s12519-015-0027-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
102 Santos L, Azevedo E. Reversible cerebral vasoconstriction syndrome - A narrative revision of the literature. Porto Biomed J 2016;1:65-71. [PMID: 32258552 DOI: 10.1016/j.pbj.2016.04.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
103 Bialasiewicz S, Hart G, Oliver K, Agnihotri SP, Koralnik IJ, Viscidi R, Nissen MD, Sloots TP, Burke MT, Isbel NM, Burke J. A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient. Transplantation 2017;101:1461-7. [PMID: 27367472 DOI: 10.1097/TP.0000000000001275] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
104 Thompson RJ, Sharp B, Pothof J, Hamedani A. Posterior reversible encephalopathy syndrome in the emergency department: case series and literature review. West J Emerg Med 2015;16:5-10. [PMID: 25671001 DOI: 10.5811/westjem.2014.12.24126] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 2.8] [Reference Citation Analysis]
105 Bartynski WS, Zeigler ZR, Shadduck RK, Lister J. Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation. Neurocrit Care 2005;3:33-45. [PMID: 16159093 DOI: 10.1385/NCC:3:1:033] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
106 Ali K, Karan A, Biswah S, Teelucksingh S, Mohammed NB. Posterior Reversible Encephalopathy Syndrome: Tips for Diagnosis and Treatment. Cureus 2021;13:e14087. [PMID: 33903844 DOI: 10.7759/cureus.14087] [Reference Citation Analysis]
107 Schmahmann JD, Smith EE, Eichler FS, Filley CM. Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann N Y Acad Sci 2008;1142:266-309. [PMID: 18990132 DOI: 10.1196/annals.1444.017] [Cited by in Crossref: 283] [Cited by in F6Publishing: 232] [Article Influence: 21.8] [Reference Citation Analysis]
108 Gao B, Yu BX, Li RS, Zhang G, Xie HZ, Liu FL, Lv C. Cytotoxic Edema in Posterior Reversible Encephalopathy Syndrome: Correlation of MRI Features with Serum Albumin Levels. AJNR Am J Neuroradiol 2015;36:1884-9. [PMID: 26138140 DOI: 10.3174/ajnr.A4379] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
109 Wake K, Imataka G, Ohnishi T, Kikuchi J, Hoshiyama E, Ono K, Yoshihara S. A Case-Study of a Child with Reversible Posterior Leukoencephalopathy Syndrome (RPLS) Associated with Severe Burns throughout the Body. Iran J Public Health 2020;49:1390-1. [PMID: 33083312 DOI: 10.18502/ijph.v49i7.3600] [Reference Citation Analysis]
110 Mohanty S, Benjamin LA, Majhi M, Panda P, Kampondeni S, Sahu PK, Mohanty A, Mahanta KC, Pattnaik R, Mohanty RR, Joshi S, Mohanty A, Turnbull IW, Dondorp AM, Taylor TE, Wassmer SC. Magnetic Resonance Imaging of Cerebral Malaria Patients Reveals Distinct Pathogenetic Processes in Different Parts of the Brain. mSphere 2017;2:e00193-17. [PMID: 28596990 DOI: 10.1128/mSphere.00193-17] [Cited by in Crossref: 50] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
111 Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011;123:2856-69. [PMID: 21690502 DOI: 10.1161/CIRCULATIONAHA.109.853127] [Cited by in Crossref: 564] [Cited by in F6Publishing: 214] [Article Influence: 56.4] [Reference Citation Analysis]
112 Barber E, Nugzar R, Finkelshtein V, Puzhevsky A, Levy T. Posterior reversible encephalopathy syndrome case report in an untreated, normotensive, ovarian cancer patient in the presence of paraneoplastic antibodies. BMC Neurol 2020;20:330. [PMID: 32878599 DOI: 10.1186/s12883-020-01913-y] [Reference Citation Analysis]
113 Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28:1320-1327. [PMID: 17698535 DOI: 10.3174/ajnr.a0549] [Cited by in Crossref: 379] [Cited by in F6Publishing: 88] [Article Influence: 27.1] [Reference Citation Analysis]
114 Fuentes AG, Komarla A, Gomez JI. Posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis. Rheumatol Int 2012;32:2529-30. [PMID: 20623125 DOI: 10.1007/s00296-010-1367-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
115 Martins WA, Marrone LC. Malignant Posterior Reversible Encephalopathy Syndrome: A Case of Posterior Irreversible Encephalopathy Syndrome. J Clin Neurol 2016;12:236-7. [PMID: 26541497 DOI: 10.3988/jcn.2016.12.2.236] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
116 Musioł K, Waz S, Boroń M, Kwiatek M, Machnikowska-Sokołowska M, Gruszczyńska K, Sobol-Milejska G. PRES in the course of hemato-oncological treatment in children. Childs Nerv Syst 2018;34:691-9. [PMID: 29198072 DOI: 10.1007/s00381-017-3664-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
117 Nagasawa H, Kurita K, Wada M, Kawanami T, Kato T. Blood transfusion-induced irreversible brain damage. J Neurol 2005;252:1541-2. [PMID: 15940385 DOI: 10.1007/s00415-005-0878-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
118 Dana R, Spartacus RK, Mutha S, Bhat P. Seizure following chemotherapy (paclitaxel and cisplatin) in a patient of carcinoma cervix. Indian J Pharmacol 2016;48:736-8. [PMID: 28066118 DOI: 10.4103/0253-7613.194863] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
119 Faille LD, Fieuws S, Van Paesschen W. Clinical predictors and differential diagnosis of posterior reversible encephalopathy syndrome. Acta Neurol Belg 2017;117:469-75. [PMID: 28144796 DOI: 10.1007/s13760-017-0750-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
120 Thompson PA, Allen CE, Horton T, Jones JY, Vinks AA, McClain KL. Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2009;52:621-625. [PMID: 19137570 DOI: 10.1002/pbc.21838] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
121 Orehek EK, Burns JD, Koyfman F, Azocar RJ, Holsapple JW, Green DM. Postpartum trifecta: simultaneous eclamptic intracerebral hemorrhage, PRES, and herniation due to intracranial hypotension. Neurocrit Care 2012;17:434-8. [PMID: 23011750 DOI: 10.1007/s12028-012-9742-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
122 Karia SJ, Rykken JB, McKinney ZJ, Zhang L, McKinney AM. Utility and Significance of Gadolinium-Based Contrast Enhancement in Posterior Reversible Encephalopathy Syndrome. AJNR Am J Neuroradiol 2016;37:415-22. [PMID: 26564441 DOI: 10.3174/ajnr.A4563] [Cited by in Crossref: 50] [Cited by in F6Publishing: 17] [Article Influence: 8.3] [Reference Citation Analysis]
123 McKinney JS, Messé SR, Pukenas BA, Satti SR, Weigele JB, Hurst RW, Levine JM, Kasner SE, Sansing LH. Intracranial vertebrobasilar artery dissection associated with postpartum angiopathy. Stroke Res Treat 2010;2010:320627. [PMID: 20700423 DOI: 10.4061/2010/320627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
124 Rangi PS, Partridge WJ, Newlands ES, Waldman AD. Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia. Neuroradiology 2005;47:586-90. [PMID: 15997391 DOI: 10.1007/s00234-005-1376-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
125 Junewar V, Verma R, Sankhwar PL, Garg RK, Singh MK, Malhotra HS, Sharma PK, Parihar A. Neuroimaging features and predictors of outcome in eclamptic encephalopathy: a prospective observational study. AJNR Am J Neuroradiol 2014;35:1728-34. [PMID: 24722310 DOI: 10.3174/ajnr.A3923] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
126 Kwon EJ, Kim SW, Kim KK, Seo HS, Kim DY. A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome. Cancer Res Treat 2009;41:53-5. [PMID: 19688073 DOI: 10.4143/crt.2009.41.1.53] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
127 Budhoo A, Mody GM. The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus. Clin Rheumatol 2015;34:2127-34. [PMID: 26298534 DOI: 10.1007/s10067-015-3055-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
128 Dagens A, Gilhooley MJ. Acute intermittent porphyria leading to posterior reversible encephalopathy syndrome (PRES): a rare cause of abdominal pain and seizures. BMJ Case Rep 2016;2016:bcr2016215350. [PMID: 27277587 DOI: 10.1136/bcr-2016-215350] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
129 Dedić Plavetić N, Rakušić Z, Ozretić D, Simetić L, Krpan AM, Bišof V. Fatal outcome of posterior "reversible" encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen. World J Surg Oncol 2014;12:264. [PMID: 25142792 DOI: 10.1186/1477-7819-12-264] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
130 Yang WC, Lin MJ, Chen CY, Wu HP. Clinical overview of hypertensive crisis in children. World J Clin Cases 2015;3:510-3. [PMID: 26090371 DOI: 10.12998/wjcc.v3.i6.510] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
131 Stracciari A, Guarino M. Neuropsychiatric complications of liver transplantation. Metab Brain Dis. 2001;16:3-11. [PMID: 11726086 DOI: 10.1023/a:1011698526025] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
132 Kapoor A, Birks E, Lenneman A, McCants K. Posterior Reversible Encephalopathy Syndrome after Heart Transplantation: Diagnosis and Immunosuppressive Therapy. Tex Heart Inst J 2017;44:205-8. [PMID: 28761402 DOI: 10.14503/THIJ-15-5007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
133 Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017;264:1608-1616. [PMID: 28054130 DOI: 10.1007/s00415-016-8377-8] [Cited by in Crossref: 152] [Cited by in F6Publishing: 69] [Article Influence: 38.0] [Reference Citation Analysis]
134 Lee YJ, Yum MS, Kim EH, Kim MJ, Kim KM, Im HJ, Kim YH, Park YS, Ko TS. Clinical Characteristics of Transplant-associated Encephalopathy in Children. J Korean Med Sci. 2017;32:457-464. [PMID: 28145649 DOI: 10.3346/jkms.2017.32.3.457] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
135 Shah RR. Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger? Drug Saf 2017;40:373-86. [PMID: 28181126 DOI: 10.1007/s40264-017-0508-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
136 Karuppannasamy D, Vikrant K, Raghuram A, Kumaar TM. Cortical visual loss in posterior reversible encephalopathy syndrome in late postpartum eclampsia: case series. Indian J Ophthalmol 2014;62:635-8. [PMID: 24881617 DOI: 10.4103/0301-4738.133525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
137 Gamie Z, Rizwan A, Balen FG, Clarke M, Hassoon MM. Posterior reversible encephalopathy syndrome in a child with cyclical vomiting and hypertension: a case report. J Med Case Rep 2011;5:137. [PMID: 21470405 DOI: 10.1186/1752-1947-5-137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
138 Alkhachroum A, Megjhani M, Terilli K, Rubinos C, Ford J, Wallace BK, Roh DJ, Agarwal S, Connolly ES, Boehme AK, Claassen J, Park S. Hyperemia in subarachnoid hemorrhage patients is associated with an increased risk of seizures. J Cereb Blood Flow Metab 2020;40:1290-9. [PMID: 31296131 DOI: 10.1177/0271678X19863028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
139 Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043-1049. [PMID: 18403560 DOI: 10.3174/ajnr.a0929] [Cited by in Crossref: 622] [Cited by in F6Publishing: 139] [Article Influence: 47.8] [Reference Citation Analysis]
140 Bux J, Sachs UJ. Pulmonary transfusion reactions. Transfus Med Hemother 2008;35:337-45. [PMID: 21512622 DOI: 10.1159/000151349] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
141 Gera DN, Patil SB, Iyer A, Kute VB, Gandhi S, Kumar D, Trivedi HL. Posterior reversible encephalopathy syndrome in children with kidney disease. Indian J Nephrol 2014;24:28-34. [PMID: 24574628 DOI: 10.4103/0971-4065.125053] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
142 Zheng YY, Weng XP, Fu FW, Cao YG, Li Y, Zheng GQ, Chen W. Cerebrospinal Fluid Hypovolemia and Posterior Reversible Encephalopathy Syndrome. Front Neurol 2020;11:591. [PMID: 32655488 DOI: 10.3389/fneur.2020.00591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Racchiusa S, Mormina E, Ax A, Musumeci O, Longo M, Granata F. Posterior reversible encephalopathy syndrome (PRES) and infection: a systematic review of the literature. Neurol Sci 2019;40:915-22. [PMID: 30604335 DOI: 10.1007/s10072-018-3651-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
144 Kwun WH. Tacrolimus related neurologic complication after pediatric kidney transplantation. J Korean Surg Soc 2011;81:225-8. [PMID: 22066126 DOI: 10.4174/jkss.2011.81.3.225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
145 Besirli CG, Sudhakar P, Wesolowski J, Trobe JD. Serous retinal detachment in hypertensive posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2011;32:E203-5. [PMID: 21393409 DOI: 10.3174/ajnr.A2435] [Cited by in Crossref: 8] [Article Influence: 0.8] [Reference Citation Analysis]
146 Chamberlain MC. Neurotoxicity of cancer treatment. Curr Oncol Rep 2010;12:60-7. [PMID: 20425609 DOI: 10.1007/s11912-009-0072-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
147 Chung DY, Claassen J, Agarwal S, Schmidt JM, Mayer SA. Assessment of Noninvasive Regional Brain Oximetry in Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome. J Intensive Care Med 2016;31:415-9. [PMID: 26732768 DOI: 10.1177/0885066615623465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
148 Emmert K, Zöller D, Preti MG, Van De Ville D, Giannakopoulos P, Haller S. Influence of Vascular Variant of the Posterior Cerebral Artery (PCA) on Cerebral Blood Flow, Vascular Response to CO2 and Static Functional Connectivity. PLoS One 2016;11:e0161121. [PMID: 27532633 DOI: 10.1371/journal.pone.0161121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
149 Yasui-Furukori N, Tarakita N, Uematsu W, Saito H, Nakamura K, Ohyama C, Sugawara N. Delirium in hemodialysis predicts mortality: a single-center, long-term observational study. Neuropsychiatr Dis Treat 2017;13:3011-6. [PMID: 29276387 DOI: 10.2147/NDT.S152355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
150 Johnson AC, Tremble SM, Chan SL, Moseley J, LaMarca B, Nagle KJ, Cipolla MJ. Magnesium sulfate treatment reverses seizure susceptibility and decreases neuroinflammation in a rat model of severe preeclampsia. PLoS One 2014;9:e113670. [PMID: 25409522 DOI: 10.1371/journal.pone.0113670] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 8.1] [Reference Citation Analysis]
151 Miksad RA, Lai KC, Stein MC, Healy ME, Rojas R, Krajewski KM, Zhu AX. Imbalance and gait disturbance from tyrosine kinase inhibition in hepatocellular cancer. J Gastrointest Cancer 2009;40:119-22. [PMID: 19894033 DOI: 10.1007/s12029-009-9086-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
152 Bushnell C, Chireau M. Preeclampsia and Stroke: Risks during and after Pregnancy. Stroke Res Treat 2011;2011:858134. [PMID: 21331165 DOI: 10.4061/2011/858134] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
153 Foreid H, Pires C, Albuquerque L, Pimentel J. Posterior reversible encephalopathy manifested by refractory status epilepticus in two patients under chemotherapy. BMJ Case Rep 2011;2011:bcr0520114181. [PMID: 22687669 DOI: 10.1136/bcr.05.2011.4181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
154 Yi JH, Ha SH, Kim YK, Choi EM. Posterior reversible encephalopathy syndrome in an untreated hypertensive patient after spinal surgery under general anesthesia -A case report-. Korean J Anesthesiol. 2011;60:369-372. [PMID: 21716568 DOI: 10.4097/kjae.2011.60.5.369] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
155 Brown CM, Garovic VD. Mechanisms and management of hypertension in pregnant women. Curr Hypertens Rep 2011;13:338-46. [PMID: 21656283 DOI: 10.1007/s11906-011-0214-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
156 Manfredi M. Neurological picture. Reversibility of brain lesions in eclampsia. J Neurol Neurosurg Psychiatry 1997;62:9. [PMID: 9010392 DOI: 10.1136/jnnp.62.1.9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
157 Kumar N, Singh R, Sharma N, Jain A. Atypical presentation of posterior reversible encephalopathy syndrome: Two cases. J Anaesthesiol Clin Pharmacol 2018;34:120-2. [PMID: 29643636 DOI: 10.4103/0970-9185.173351] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
158 Saner FH, Gensicke J, Olde Damink SW, Pavlaković G, Treckmann J, Dammann M, Kaiser GM, Sotiropoulos GC, Radtke A, Koeppen S, Beckebaum S, Cicinnati V, Nadalin S, Malagó M, Paul A, Broelsch CE. Neurologic complications in adult living donor liver transplant patients: an underestimated factor? J Neurol 2010;257:253-8. [PMID: 19727899 DOI: 10.1007/s00415-009-5303-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
159 Elmalik HH, ElAzzazy S, Salem KS, Bujassoum S. A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer. Case Rep Oncol 2015;8:290-4. [PMID: 26351436 DOI: 10.1159/000435805] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
160 Tlemsani C, Mir O, Boudou-Rouquette P, Huillard O, Maley K, Ropert S, Coriat R, Goldwasser F. Posterior reversible encephalopathy syndrome induced by anti-VEGF agents. Target Oncol 2011;6:253-8. [PMID: 22090260 DOI: 10.1007/s11523-011-0201-x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 43] [Article Influence: 7.9] [Reference Citation Analysis]
161 Suzuki D, Kobayashi R, Iguchi A, Sano H, Kishimoto K, Yasuda K, Kobayashi K. Tumor lysis syndrome as a risk factor for posterior reversible encephalopathy syndrome in children with hematological malignancies. Int J Hematol 2014;100:485-9. [PMID: 25216697 DOI: 10.1007/s12185-014-1658-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
162 Aranas RM, Prabhakaran S, Lee VH. Posterior reversible encephalopathy syndrome associated with hemorrhage. Neurocrit Care. 2009;10:306-312. [PMID: 19225908 DOI: 10.1007/s12028-009-9200-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
163 Haughey D, Narsipur SS. Posterior reversible encephalopathy syndrome after renal transplant: a simple solution for a complicated patient. Case Rep Nephrol Dial 2015;5:20-5. [PMID: 25849670 DOI: 10.1159/000366554] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
164 Kane SC, Dennis A, da Silva Costa F, Kornman L, Brennecke S. Contemporary clinical management of the cerebral complications of preeclampsia. Obstet Gynecol Int 2013;2013:985606. [PMID: 24489551 DOI: 10.1155/2013/985606] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
165 Nan D, Yin X, Ma D, Jiang X, Wu B, Feng J. Posterior Reversible Encephalopathy Syndrome Associated With Anlotinib: A Case Report and Literature Review. Front Neurol 2021;12:546481. [PMID: 34025545 DOI: 10.3389/fneur.2021.546481] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Singer S, Grommes C, Reiner AS, Rosenblum MK, DeAngelis LM. Posterior Reversible Encephalopathy Syndrome in Patients With Cancer. Oncologist 2015;20:806-11. [PMID: 26032137 DOI: 10.1634/theoncologist.2014-0149] [Cited by in Crossref: 56] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
167 Chang Y, Mbeo G, Littman SJ. Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma. J Gastrointest Cancer 2012;43:505-7. [PMID: 21556724 DOI: 10.1007/s12029-011-9279-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
168 Frick D, Huecker M, Shoff H. Posterior Reversible Encephalopathy Syndrome Presenting as Stroke Mimic. Clin Pract Cases Emerg Med 2017;1:171-4. [PMID: 29849301 DOI: 10.5811/cpcem.2017.1.30607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
169 Parameswaran BK, Krishnan PR, Al Dossary J. Recurrent posterior reversible encephalopathy syndrome in a patient with sickle cell disease. Ann Saudi Med 2007;27:206-11. [PMID: 17568161 DOI: 10.5144/0256-4947.2007.206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
170 Kitaguchi H, Tomimoto H, Miki Y, Yamamoto A, Terada K, Satoi H, Kanda M, Fukuyama H. A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology 2005;47:652-6. [PMID: 15947925 DOI: 10.1007/s00234-005-1399-z] [Cited by in Crossref: 46] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
171 Yamada A, Ueda N. Age and gender may affect posterior reversible encephalopathy syndrome in renal disease. Pediatr Nephrol 2012;27:277-83. [PMID: 21822908 DOI: 10.1007/s00467-011-1974-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
172 Yoon SD, Cho BM, Oh SM, Park SH, Jang IB, Lee JY. Clinical and radiological spectrum of posterior reversible encephalopathy syndrome. J Cerebrovasc Endovasc Neurosurg 2013;15:206-13. [PMID: 24167801 DOI: 10.7461/jcen.2013.15.3.206] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
173 Giraldo EA, Fugate JE, Rabinstein AA, Lanzino G, Wijdicks EF. Posterior reversible encephalopathy syndrome associated with hemodynamic augmentation in aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011;14:427-32. [PMID: 21327576 DOI: 10.1007/s12028-011-9515-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
174 Kabre RS, Kamble KM. Gemcitabine and Cisplatin induced posterior reversible encephalopathy syndrome: A case report with review of literature. J Res Pharm Pract 2016;5:297-300. [PMID: 27843969 DOI: 10.4103/2279-042X.192464] [Cited by in Crossref: 9] [Article Influence: 1.8] [Reference Citation Analysis]
175 Kim TK, Yoon JU, Park SC, Lee HJ, Kim WS, Yoon JY. Postoperative blindness associated with posterior reversible encephalopathy syndrome: a case report. J Anesth. 2010;24:783-785. [PMID: 20694483 DOI: 10.1007/s00540-010-0995-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
176 Ohta T, Sakano T, Shiotsu M, Furue T, Ohtani H, Kinoshita Y, Mizoue T, Kiya K, Tanaka I. Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis. Pediatr Nephrol 2004;19:442-4. [PMID: 14677053 DOI: 10.1007/s00467-003-1286-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
177 Campagna F, Biancardi A, Cillo U, Gatta A, Amodio P. Neurocognitive-neurological complications of liver transplantation: a review. Metab Brain Dis. 2010;25:115-124. [PMID: 20204483 DOI: 10.1007/s11011-010-9183-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
178 Ikonomidou C. Chemotherapy and the pediatric brain. Mol Cell Pediatr 2018;5:8. [PMID: 30402806 DOI: 10.1186/s40348-018-0087-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
179 Stevens CJ, Heran MK. The many faces of posterior reversible encephalopathy syndrome. Br J Radiol 2012;85:1566-75. [PMID: 23175479 DOI: 10.1259/bjr/25273221] [Cited by in Crossref: 85] [Cited by in F6Publishing: 43] [Article Influence: 10.6] [Reference Citation Analysis]
180 Sudulagunta SR, Sodalagunta MB, Kumbhat M, Settikere Nataraju A. Posterior reversible encephalopathy syndrome(PRES). Oxf Med Case Reports 2017;2017:omx011. [PMID: 28473920 DOI: 10.1093/omcr/omx011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
181 Fischer M, Schmutzhard E. [Posterior reversible encephalopathy syndrome]. Med Klin Intensivmed Notfmed 2016;111:417-24. [PMID: 27272329 DOI: 10.1007/s00063-016-0175-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
182 Nakagawa K, Serrador JM, Larose SL, Moslehi F, Lipsitz LA, Sorond FA. Autoregulation in the posterior circulation is altered by the metabolic state of the visual cortex. Stroke 2009;40:2062-7. [PMID: 19359628 DOI: 10.1161/STROKEAHA.108.545285] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
183 Kalaiselvan MS, Renuka MK, Arunkumar AS. Clinical Features and Outcomes of Patients with Posterior Reversible Encephalopathy Syndrome. Indian J Crit Care Med 2017;21:453-6. [PMID: 28808366 DOI: 10.4103/ijccm.IJCCM_79_17] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
184 Gandhi CD, Meyer SA, Patel AB, Johnson DM, Post KD. Neurologic complications of inferior petrosal sinus sampling. AJNR Am J Neuroradiol 2008;29:760-5. [PMID: 18238844 DOI: 10.3174/ajnr.A0930] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
185 Schilder RJ, Sill MW, Lankes HA, Gold MA, Mannel RS, Modesitt SC, Hanjani P, Bonebrake AJ, Sood AK, Godwin AK, Hu W, Alpaugh RK. A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study. Gynecol Oncol 2013;129:86-91. [PMID: 23321064 DOI: 10.1016/j.ygyno.2013.01.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
186 Ogawa A, Sugiyama H, Nakayama K, Morinaga H, Akagi S, Makino H. Reversible posterior leukoencephalopathy syndrome in a young adult patient receiving peritoneal dialysis. Perit Dial Int 2012;32:587-9. [PMID: 23212857 DOI: 10.3747/pdi.2011.00055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
187 Tripathi R, Rath G, Ralhan R, Saxena S, Salhan S. Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsia. Yonsei Med J 2009;50:656-66. [PMID: 19881969 DOI: 10.3349/ymj.2009.50.5.656] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
188 Hu H, Xu S, Hu S, Xu W, Shui H. The clinical characteristics of posterior reversible encephalopathy syndrome in patients with chronic renal failure. Exp Ther Med 2017;14:881-7. [PMID: 28673014 DOI: 10.3892/etm.2017.4570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Kelly DL, Buchbinder D, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick A, Wirk BM, Yi J, Battiwalla M, Flowers ME, Savani B, Shaw BE. Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2018;24:228-41. [PMID: 28939455 DOI: 10.1016/j.bbmt.2017.09.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
190 Onder AM, Lopez R, Teomete U, Francoeur D, Bhatia R, Knowbi O, Hizaji R, Chandar J, Abitbol C, Zilleruelo G. Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol 2007;22:1921-9. [PMID: 17694337 DOI: 10.1007/s00467-007-0578-z] [Cited by in Crossref: 76] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
191 Charuvanij S, Houghton KM. Acute epiglottitis as the initial presentation of pediatric Systemic Lupus Erythematosus. Pediatr Rheumatol Online J 2009;7:19. [PMID: 19878586 DOI: 10.1186/1546-0096-7-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
192 Legriel S, Bruneel F, Spreux-Varoquaux O, Birenbaum A, Chadenat ML, Mignon F, Abbosh N, Henry-Lagarrigue M, Revault D'Allonnes L, Guezennec P, Troche G, Bedos JP. Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus. Neurocrit Care 2008;9:247-52. [PMID: 18446448 DOI: 10.1007/s12028-008-9096-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
193 Raina S, Mahesh D, Rajendra G, Chauhan NS. Reversible posterior leukoencephalopathy syndrome. J Neurosci Rural Pract 2012;3:222-4. [PMID: 22865991 DOI: 10.4103/0976-3147.98262] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
194 Prasad M, Wetzler G, Holtmann J, Dapul H, Kupferman JC. Constipation, renovascular hypertension, and posterior reversible encephalopathy syndrome (PRES). Eur J Pediatr 2016;175:421-5. [PMID: 26319009 DOI: 10.1007/s00431-015-2627-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
195 Herisson F, Zhou I, Mawet J, Du E, Barfejani AH, Qin T, Cipolla MJ, Sun PZ, Rost NS, Ayata C. Posterior reversible encephalopathy syndrome in stroke-prone spontaneously hypertensive rats on high-salt diet. J Cereb Blood Flow Metab 2019;39:1232-46. [PMID: 29350576 DOI: 10.1177/0271678X17752795] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
196 Weidauer S, Wagner M, Enkirch SJ, Hattingen E. CNS Infections in Immunoincompetent Patients : Neuroradiological and Clinical Features. Clin Neuroradiol 2020;30:9-25. [PMID: 31538219 DOI: 10.1007/s00062-019-00837-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
197 Schreurs MP, Cipolla MJ, Al-Nasiry S, Peeters LL, Spaanderman ME. Formerly eclamptic women have lower nonpregnant blood pressure compared with formerly pre-eclamptic women: a retrospective cohort study. BJOG 2015;122:1403-9. [PMID: 25753846 DOI: 10.1111/1471-0528.13285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
198 Lodish M, Patronas NJ, Stratakis CA. Reversible posterior encephalopathy syndrome associated with micronodular adrenocortical disease and Cushing syndrome. Eur J Pediatr 2010;169:125-6. [PMID: 19415327 DOI: 10.1007/s00431-009-0990-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
199 Zhang P, Li X, Li Y, Wang J, Zeng H, Zeng X. Reversible posterior leukoencephalopathy syndrome secondary to systemic-onset juvenile idiopathic arthritis: A case report and review of the literature. Biomed Rep 2015;3:55-8. [PMID: 25469247 DOI: 10.3892/br.2014.380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
200 Liu JH, Fan HS, Deng SH, Sui WW, Fu MW, Yi SH, Huang WY, Li ZJ, Zhang CX, Zou DH, Zhao YZ, Qiu LG, An G. [Central nervous system toxicity caused by bortezomib: five case reports and a review of literature]. Zhonghua Xue Ye Xue Za Zhi 2021;42:63-9. [PMID: 33677871 DOI: 10.3760/cma.j.issn.0253-2727.2021.01.012] [Reference Citation Analysis]
201 Bianco F. Reversible posterior leukoencephalopathy syndrome: a changing concept. Neuroradiology 2005;47:703-4; author reply 705. [PMID: 15951996 DOI: 10.1007/s00234-005-1403-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
202 Siebert E, Bohner G, Endres M, Liman TG. Clinical and radiological spectrum of posterior reversible encephalopathy syndrome: does age make a difference?--A retrospective comparison between adult and pediatric patients. PLoS One 2014;9:e115073. [PMID: 25514795 DOI: 10.1371/journal.pone.0115073] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
203 Mohammed H, Briggs M, Phillips J. Pulsatile tinnitus as the presenting symptom in a patient with posterior reversible encephalopathy syndrome. Eur Arch Otorhinolaryngol 2016;273:2847-51. [PMID: 26661070 DOI: 10.1007/s00405-015-3847-7] [Reference Citation Analysis]
204 Karande S, Jagtap S, Joshi A. Posterior reversible encephalopathy syndrome revealing Takayasu's arteritis. Indian J Pediatr 2009;76:218-20. [PMID: 19082534 DOI: 10.1007/s12098-008-0224-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
205 Hefzy HM, Bartynski WS, Boardman JF, Lacomis D. Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol. 2009;30:1371-1379. [PMID: 19386731 DOI: 10.3174/ajnr.a1588] [Cited by in Crossref: 194] [Cited by in F6Publishing: 52] [Article Influence: 16.2] [Reference Citation Analysis]
206 Hughes HC, Blackburn D. Blindness in a case of tetanus. J Neurol Neurosurg Psychiatry 2006;77:420-1. [PMID: 16484660 DOI: 10.1136/jnnp.2005.071597] [Reference Citation Analysis]
207 Khanal S, Acharya SP. Posterior reversible encephalopathy syndrome in association with exacerbation of chronic obstructive pulmonary disease: a case report. BMC Neurol 2018;18:180. [PMID: 30382822 DOI: 10.1186/s12883-018-1188-z] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
208 Harshman LC, Srinivas S. The bevacizumab experience in advanced renal cell carcinoma. Onco Targets Ther 2010;3:179-89. [PMID: 21049084 DOI: 10.2147/ott.s8157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
209 Papaconstantinou I, Mantzos DS, Pantiora E, Tasoulis MK, Vassilopoulou S, Mantzaris G. Posterior reversible encephalopathy syndrome following sepsis in a Crohn's disease patient: A case report. World J Clin Cases 2016;4:103-7. [PMID: 27099860 DOI: 10.12998/wjcc.v4.i4.103] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
210 Sloan MA, Stern BJ. Cerebrovascular Disease in Pregnancy. Curr Treat Options Neurol 2003;5:391-407. [PMID: 12895402 DOI: 10.1007/s11940-003-0030-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
211 Legriel S, Schraub O, Azoulay E, Hantson P, Magalhaes E, Coquet I, Bretonniere C, Gilhodes O, Anguel N, Megarbane B, Benayoun L, Schnell D, Plantefeve G, Charpentier J, Argaud L, Mourvillier B, Galbois A, Chalumeau-Lemoine L, Rivoal M, Durand F, Geffroy A, Simon M, Stoclin A, Pallot JL, Arbelot C, Nyunga M, Lesieur O, Troché G, Bruneel F, Cordoliani YS, Bedos JP, Pico F; Critically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS). Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One 2012;7:e44534. [PMID: 23024751 DOI: 10.1371/journal.pone.0044534] [Cited by in Crossref: 92] [Cited by in F6Publishing: 57] [Article Influence: 10.2] [Reference Citation Analysis]
212 Yoon JE, Lee CY, Kim HW. Posterior Reversible Encephalopathy Syndrome after Head Trauma Surgery in Pediatric Patient without Any Underlying Disease. Korean J Neurotrauma 2017;13:167-70. [PMID: 29201855 DOI: 10.13004/kjnt.2017.13.2.167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
213 Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85:427-432. [PMID: 20435835 DOI: 10.4065/mcp.2009.0590] [Cited by in Crossref: 466] [Cited by in F6Publishing: 240] [Article Influence: 42.4] [Reference Citation Analysis]
214 González-Suárez I, Aguilar-Amat MJ, Trigueros M, Borobia AM, Cruz A, Arpa J. Leukoencephalopathy due to oral methotrexate. Cerebellum 2014;13:178-83. [PMID: 24068485 DOI: 10.1007/s12311-013-0528-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
215 Yadav D, Garg L, Narwal P, Ladkany R, Franey L. Concomitant takotsubo cardiomyopathy with PRES syndrome: A coincidence or a real heart-brain connection? J Cardiol Cases 2015;12:48-51. [PMID: 30524539 DOI: 10.1016/j.jccase.2015.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
216 Winton-Brown TT, Ting A, Mocellin R, Walterfang M, Velakoulis D, Gaillard F. Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations. AJNR Am J Neuroradiol 2016;37:774-81. [PMID: 26744445 DOI: 10.3174/ajnr.A4636] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Drye C, Bose S, Pathireddy S, Aeddula NR. Guillain-Barre syndrome with concurrent posterior reversible encephalopathy syndrome and hyponatraemia: mere coincidence or rare coexistence. BMJ Case Rep 2019;12:e229749. [PMID: 31300598 DOI: 10.1136/bcr-2019-229749] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Camara-Lemarroy CR, Lara-Campos JG, Perez-Contreras E, Rodríguez-Gutiérrez R, Galarza-Delgado DA. Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review. Clin Rheumatol 2013;32:409-15. [PMID: 23292521 DOI: 10.1007/s10067-012-2151-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
219 Hun M, Xie M, She Z, Abdirahman AS, Li C, Wu F, Luo S, Han P, Phorn R, Wu P, Luo H, Chen K, Tian J, Wan W, Wen C. Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size. Front Pediatr 2021;9:678890. [PMID: 34277519 DOI: 10.3389/fped.2021.678890] [Reference Citation Analysis]
220 Siddiqi AI. Rituximab as a possible cause of posterior reversible encephalopathy syndrome. Australas Med J 2011;4:513-5. [PMID: 23393543 DOI: 10.4066/AMJ.2011.627] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
221 Lifson N, Pasquale A, Salloum G, Alpert S. Ophthalmic Manifestations of Posterior Reversible Encephalopathy Syndrome. Neuroophthalmology 2019;43:180-4. [PMID: 31312242 DOI: 10.1080/01658107.2018.1506938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
222 Kaarthigeyan K, Vijayalakshmi AM. Cortical blindness in a child with acute glomerulonephritis. Indian J Nephrol 2012;22:42-4. [PMID: 22279342 DOI: 10.4103/0971-4065.86408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
223 Munjuluri N, Lipman M, Valentine A, Hardiman P, Maclean AB. Postpartum eclampsia of late onset. BMJ 2005;331:1070-1. [PMID: 16269495 DOI: 10.1136/bmj.331.7524.1070] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
224 Navinan MR, Subasinghe CJ, Kandeepan T, Kulatunga A. Polyarteritis nodosa complicated by posterior reversible encephalopathy syndrome: a case report. BMC Res Notes 2014;7:89. [PMID: 24529495 DOI: 10.1186/1756-0500-7-89] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
225 Zahir MN, Masood N, Shabbir-Moosajee M. Cisplatin-induced posterior reversible encephalopathy syndrome and successful re-treatment in a patient with non-seminomatous germ cell tumor: a case report. J Med Case Rep 2012;6:409. [PMID: 23194133 DOI: 10.1186/1752-1947-6-409] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
226 Chae YK, Chiec L, Adney SK, Waitzman J, Costa R, Carneiro B, Matsangou M, Agulnik M, Kopp P, Giles F. Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review. Oncotarget 2018;9:28281-9. [PMID: 29963277 DOI: 10.18632/oncotarget.25606] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
227 Fisler G, Monty MA, Kohn N, Assaad P, Trope R, Kessel A. Characteristics and Outcomes of Critically Ill Pediatric Patients with Posterior Reversible Encephalopathy Syndrome. Neurocrit Care 2020;32:145-51. [PMID: 31069660 DOI: 10.1007/s12028-019-00720-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
228 Siebert E, Bohner G, Liebig T, Endres M, Liman TG. Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study. J Neurol 2017;264:237-42. [PMID: 27815684 DOI: 10.1007/s00415-016-8328-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 5.6] [Reference Citation Analysis]
229 Scantlebury DC, Schwartz GL, Acquah LA, White WM, Moser M, Garovic VD. The treatment of hypertension during pregnancy: when should blood pressure medications be started? Curr Cardiol Rep. 2013;15:412. [PMID: 24057769 DOI: 10.1007/s11886-013-0412-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
230 de Brabander C, Cornelissen J, Smitt PA, Vecht CJ, van den Bent MJ. Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors. J Neurol Neurosurg Psychiatry 2000;68:36-40. [PMID: 10601399 DOI: 10.1136/jnnp.68.1.36] [Cited by in Crossref: 63] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
231 Ogunneye O, Hernandez-Montfort JA, Ogunneye Y, Ogu I, Landry D. Parainfluenza virus infection associated with posterior reversible encephalopathy syndrome: a case report. J Med Case Rep 2012;6:89. [PMID: 22448715 DOI: 10.1186/1752-1947-6-89] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
232 Merayo-Chalico J, Barrera-Vargas A, Juárez-Vega G, Alcocer-Varela J, Arauz A, Gómez-Martín D. Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome. Clin Exp Immunol 2018;192:165-70. [PMID: 29271478 DOI: 10.1111/cei.13095] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
233 Li K, Yang Y, Guo D, Sun D, Li C. Clinical and MRI Features of Posterior Reversible Encephalopathy Syndrome With Atypical Regions: A Descriptive Study With a Large Sample Size. Front Neurol 2020;11:194. [PMID: 32265829 DOI: 10.3389/fneur.2020.00194] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
234 Lukas C, Keyvani K, Börnke C. Primary angiitis of the central nervous system presenting with subacute and fatal course of disease: a case report. BMC Neurol 2005;5:16. [PMID: 16162278 DOI: 10.1186/1471-2377-5-16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
235 Yang WC, Zhao LL, Chen CY, Wu YK, Chang YJ, Wu HP. First-attack pediatric hypertensive crisis presenting to the pediatric emergency department. BMC Pediatr 2012;12:200. [PMID: 23272766 DOI: 10.1186/1471-2431-12-200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
236 Broniscer A, Baker JN, Tagen M, Onar-Thomas A, Gilbertson RJ, Davidoff AM, Pai Panandiker AS, Leung W, Chin TK, Stewart CF, Kocak M, Rowland C, Merchant TE, Kaste SC, Gajjar A. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol 2010;28:4762-8. [PMID: 20921456 DOI: 10.1200/JCO.2010.30.3545] [Cited by in Crossref: 83] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
237 Patel UV, Patel NJ. Posterior reversible leukoencephalopathy syndrome as a presenting manifestation of p-ANCA-associated vasculitis. BMJ Case Rep 2014;2014:bcr2013202022. [PMID: 24855074 DOI: 10.1136/bcr-2013-202022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
238 Donmez FY, Guleryuz P, Agildere M. MRI Findings in Childhood PRES: What is Different than the Adults? Clin Neuroradiol 2016;26:209-13. [PMID: 25293448 DOI: 10.1007/s00062-014-0350-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
239 Niyadurupola N, Burnett CA, Allen LE. Reversible posterior leucoencephalopathy syndrome: a cause of temporary cortical blindness. Br J Ophthalmol 2005;89:924-5. [PMID: 15965184 DOI: 10.1136/bjo.2004.060400] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
240 Sundgren PC, Dong Q, Gómez-Hassan D, Mukherji SK, Maly P, Welsh R. Diffusion tensor imaging of the brain: review of clinical applications. Neuroradiology 2004;46:339-50. [PMID: 15103435 DOI: 10.1007/s00234-003-1114-x] [Cited by in Crossref: 298] [Cited by in F6Publishing: 216] [Article Influence: 17.5] [Reference Citation Analysis]
241 Deguchi S, Mitsuya K, Nakasu Y, Hayashi N, Katagiri H, Murata H, Wasa J, Takahashi M, Endo M. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature. Invest New Drugs 2018;36:346-9. [PMID: 29067537 DOI: 10.1007/s10637-017-0521-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
242 Cha B, Kim DY, Jang H, Hwang SD, Choi HJ, Kim MJ. Unusual Case of Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-glomerular Basement Membrane Antibody Glomerulonephritis: A Case Report and Review of the Literature. Electrolyte Blood Press 2017;15:12-6. [PMID: 29042902 DOI: 10.5049/EBP.2017.15.1.12] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
243 Osawa Y, Gozawa R, Koyama K, Nakayama T, Sagoh T, Sunaga H. Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Anaplastic Thyroid Carcinoma. Intern Med 2018;57:1015-9. [PMID: 29225265 DOI: 10.2169/internalmedicine.9593-17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
244 Abbas O, Shamseddin A, Temraz S, Haydar A. Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient. BMJ Case Rep 2013;2013:bcr2012007995. [PMID: 23436889 DOI: 10.1136/bcr-2012-007995] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
245 Rodriguez M, Moreno J, Hasbun J. RAS in Pregnancy and Preeclampsia and Eclampsia. Int J Hypertens 2012;2012:739274. [PMID: 23346385 DOI: 10.1155/2012/739274] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
246 Hun M, Tian J, Xie M, She Z, Abdirahman AS, Han P, Wan W, Wen C. Analysis of Risk Factors Associated With Poor Outcome in Posterior Reversible Encephalopathy Syndrome After Treatment in Children: Systematic Review and Meta-Analysis. Front Neurol 2020;11:938. [PMID: 32982945 DOI: 10.3389/fneur.2020.00938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
247 Fukui S, Toyoshima Y, Inoue T, Kagebayashi Y, Samma S. Reversible Posterior Leukoencephalopathy Syndrome Developing After Restart of Sunitinib Therapy for Metastatic Renal Cell Carcinoma. Case Rep Med 2016;2016:6852951. [PMID: 27795711 DOI: 10.1155/2016/6852951] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
248 Kim Y, Kwak J, Jung S, Lee S, Jang HN, Cho HS, Chang SH, Kim HJ. Oral cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis: A case report. World J Clin Cases 2021;9:6130-7. [PMID: 34368335 DOI: 10.12998/wjcc.v9.i21.6130] [Reference Citation Analysis]
249 Saner F, Gu Y, Minouchehr S, Ilker K, Fruhauf NR, Paul A, Radtke A, Dammann M, Katsarava Z, Koeppen S. Neurological complications after cadaveric and living donor liver transplantation. J Neurol. 2006;253:612-617. [PMID: 16511638 DOI: 10.1007/s00415-006-0069-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
250 Burn DJ, Bates D. Neurology and the kidney. J Neurol Neurosurg Psychiatry 1998;65:810-21. [PMID: 9854955 DOI: 10.1136/jnnp.65.6.810] [Cited by in Crossref: 139] [Cited by in F6Publishing: 86] [Article Influence: 6.3] [Reference Citation Analysis]
251 Ozcakar ZB, Ekim M, Fitoz S, Teber S, Hizel S, Acar B, Yüksel S, Yalcinkaya F. Hypertension induced reversible posterior leukoencephalopathy syndrome: a report of two cases. Eur J Pediatr 2004;163:728-30. [PMID: 15322868 DOI: 10.1007/s00431-004-1532-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
252 Bhatt A, Farooq MU, Majid A, Kassab M. Chemotherapy-related posterior reversible leukoencephalopathy syndrome. Nat Clin Pract Neurol 2009;5:163-9. [PMID: 19262592 DOI: 10.1038/ncpneuro1045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
253 Yu WL, Leung T, Soo Y, Lee J, Wong KS. Thrombotic thrombocytopenic purpura with concomitant small- and large-vessel thrombosis, atypical posterior reversible encephalopathy syndrome and cerebral microbleeds. Oxf Med Case Reports 2015;2015:179-82. [PMID: 25988072 DOI: 10.1093/omcr/omv001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
254 Fukushima Y, Nakahara I. Delayed leucoencephalopathy after coil embolisation of unruptured cerebral aneurysm. BMJ Case Rep 2018;2018:bcr-2018-224569. [PMID: 29936444 DOI: 10.1136/bcr-2018-224569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
255 Deepak P, Loftus EV Jr. Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapy. Drug Des Devel Ther 2016;10:3685-98. [PMID: 27956825 DOI: 10.2147/DDDT.S102141] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 5.8] [Reference Citation Analysis]
256 Marrone LC, Gadonski G, Diogo LP, Brunelli JP, Martins WA, Laguna Gde O, Bahlis LF, Filho JR, da Costa BE, Poli-de-Figueiredo CE, Marrone AC, da Costa JC. Posterior reversible encephalopathy syndrome: differences between pregnant and non-pregnant patients. Neurol Int 2014;6:5376. [PMID: 24744848 DOI: 10.4081/ni.2014.5376] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
257 Chen H, Modiano MR, Neal JW, Brahmer JR, Rigas JR, Jotte RM, Leighl NB, Riess JW, Kuo CJ, Liu L, Gao B, Dicioccio AT, Adjei AA, Wakelee HA. A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer. Br J Cancer 2014;110:602-8. [PMID: 24292447 DOI: 10.1038/bjc.2013.735] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
258 Diaz-Padilla I, Siu LL, San Pedro-Salcedo M, Razak AR, Colevas AD, Shepherd FA, Leighl NB, Neal JW, Thibault A, Liu L. A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours. Br J Cancer. 2012;107:604-611. [PMID: 22805331 DOI: 10.1038/bjc.2012.319] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
259 Ogura S, Narumiya H, Iiduka R, Nagakane Y. Late recovery from unconsciousness in a patient with severe posterior reversible encephalopathy syndrome. Clin Case Rep 2018;6:1825-8. [PMID: 30214772 DOI: 10.1002/ccr3.1740] [Reference Citation Analysis]
260 Tsukamoto S, Takeuchi M, Kawajiri C, Tanaka S, Nagao Y, Sugita Y, Yamazaki A, Kawaguchi T, Muto T, Sakai S, Takeda Y, Ohwada C, Sakaida E, Shimizu N, Yokote K, Iseki T, Nakaseko C. Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy. Int J Hematol 2012;95:204-8. [PMID: 22160836 DOI: 10.1007/s12185-011-0982-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
261 Parauda SC, Gao V, Gewirtz AN, Parikh NS, Merkler AE, Lantos J, White H, Leifer D, Navi BB, Segal AZ. Posterior reversible encephalopathy syndrome in patients with COVID-19. J Neurol Sci 2020;416:117019. [PMID: 32679347 DOI: 10.1016/j.jns.2020.117019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 35.0] [Reference Citation Analysis]
262 Davi CB, Moraes BP, Lichtenfels BF, Castro Filho JBS, Portal MM, Montenegro RM, Manfro RC. Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case report. J Bras Nefrol 2018;40:91-4. [PMID: 29796585 DOI: 10.1590/1678-4685-JBN-3825] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Khan SJ, Arshad AA, Fayyaz MB, Ud Din Mirza I. Posterior Reversible Encephalopathy Syndrome in Pediatric Cancer: Clinical and Radiologic Findings. J Glob Oncol 2018;4:1-8. [PMID: 30241146 DOI: 10.1200/JGO.17.00089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
264 Cipolla MJ, Sweet JG, Chan SL. Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J Appl Physiol (1985) 2011;110:329-39. [PMID: 21071591 DOI: 10.1152/japplphysiol.01159.2010] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 5.5] [Reference Citation Analysis]
265 Kurukumbi M, Castellanos MI, Crawford AK, Gowdar SD, Jayam-Trouth A. Posterior Reversible Encephalopathy Syndrome in a Patient with Newly Diagnosed HIV Infection and End Stage Renal Disease. Case Rep Neurol Med 2013;2013:473618. [PMID: 23738165 DOI: 10.1155/2013/473618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
266 Zappella N, Perier F, Pico F, Palette C, Muret A, Merceron S, Girbovan A, Marquion F, Legriel S. Duloxetine-related posterior reversible encephalopathy syndrome: A case report. Medicine (Baltimore) 2016;95:e4556. [PMID: 27537580 DOI: 10.1097/MD.0000000000004556] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
267 Zemple RP, Pelleg T, Cossio MR. An Unusual Case of Posterior Reversible Encephalopathy Syndrome. Clin Pract Cases Emerg Med 2017;1:208-11. [PMID: 29849324 DOI: 10.5811/cpcem.2017.3.30999] [Reference Citation Analysis]
268 Agapidou A, Aiken L, Linpower L, Tsitsikas DA. Ischemic Monomeric Neuropathy in a Woman with Sickle Cell Anaemia. Case Rep Hematol 2016;2016:8628425. [PMID: 27994894 DOI: 10.1155/2016/8628425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
269 Mathew RM, Rosenfeld MR. Neurologic Complications of Bone Marrow and Stem-cell Transplantation in Patients with Cancer. Curr Treat Options Neurol 2007;9:308-14. [PMID: 17580010 DOI: 10.1007/s11940-007-0016-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
270 Jabrane M, Ait Lahcen Z, Fadili W, Laouad I. A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide. Rheumatol Int. 2015;35:935-938. [PMID: 25387825 DOI: 10.1007/s00296-014-3173-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
271 Song T, Rao Z, Tan Q, Qiu Y, Liu J, Huang Z, Wang X, Lin T. Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review. Medicine (Baltimore). 2016;95:e3173. [PMID: 27057842 DOI: 10.1097/md.0000000000003173] [Cited by in Crossref: 42] [Cited by in F6Publishing: 12] [Article Influence: 8.4] [Reference Citation Analysis]
272 Nakamura Y, Sugino M, Tsukahara A, Nakazawa H, Yamamoto N, Arawaka S. Posterior reversible encephalopathy syndrome with extensive cytotoxic edema after blood transfusion: a case report and literature review. BMC Neurol 2018;18:190. [PMID: 30419835 DOI: 10.1186/s12883-018-1194-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
273 Rastogi A, Kaur J, Hyder R, Bhaskar B, Upadhyaya V, Rai AS. A case of post-operative posterior reversible encephalopathy syndrome in children: A preventable neurological catastrophe. Indian J Anaesth 2020;64:62-5. [PMID: 32001911 DOI: 10.4103/ija.IJA_437_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
274 Chen TH. Childhood Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Characteristics, Managements, and Outcome. Front Pediatr 2020;8:585. [PMID: 33042923 DOI: 10.3389/fped.2020.00585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
275 Grewal J, Grewal HK, Forman AD. Seizures and epilepsy in cancer: etiologies, evaluation, and management. Curr Oncol Rep 2008;10:63-71. [PMID: 18366962 DOI: 10.1007/s11912-008-0010-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
276 Lee WJ, Yeon JY, Jo KI, Kim JS, Hong SC. Reversible Cerebral Vasoconstriction Syndrome and Posterior Reversible Encephalopathy Syndrome Presenting with Deep Intracerebral Hemorrhage in Young Women. J Cerebrovasc Endovasc Neurosurg 2015;17:239-45. [PMID: 26523259 DOI: 10.7461/jcen.2015.17.3.239] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
277 Sigurtà A, Terzi V, Regna-Gladin C, Fumagalli R. Posterior Reversible Encephalopathy Syndrome Complicating Traumatic Pancreatitis: A Pediatric Case Report. Medicine (Baltimore) 2016;95:e3758. [PMID: 27258506 DOI: 10.1097/MD.0000000000003758] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
278 Hosley CM, McCullough LD. Acute neurological issues in pregnancy and the peripartum. Neurohospitalist 2011;1:104-16. [PMID: 23983844 DOI: 10.1177/1941875211399126] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
279 Pirker A, Kramer L, Voller B, Loader B, Auff E, Prayer D. Type of edema in posterior reversible encephalopathy syndrome depends on serum albumin levels: an MR imaging study in 28 patients. AJNR Am J Neuroradiol 2011;32:527-31. [PMID: 21252042 DOI: 10.3174/ajnr.A2332] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
280 Kumar A, Keyrouz SG, Willie JT, Dhar R. Reversible obstructive hydrocephalus from hypertensive encephalopathy. Neurocrit Care 2012;16:433-9. [PMID: 22234407 DOI: 10.1007/s12028-011-9663-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
281 Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick AB, Wirk BM, Yi J, Battiwalla M, Flowers MDE, Savani B, Shaw BE. Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplant 2018;53:535-55. [PMID: 29343837 DOI: 10.1038/s41409-017-0055-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 12.3] [Reference Citation Analysis]
282 Kassim AA, Galadanci NA, Pruthi S, DeBaun MR. How I treat and manage strokes in sickle cell disease. Blood. 2015;125:3401-3410. [PMID: 25824688 DOI: 10.1182/blood-2014-09-551564] [Cited by in Crossref: 74] [Cited by in F6Publishing: 46] [Article Influence: 12.3] [Reference Citation Analysis]
283 Ge YT, Liao JL, Liang W, Xiong ZY. Anti-Glomerular Basement Membrane Disease Combined with IgA Nephropathy Complicated with Reversible Posterior Leukoencephalopathy Syndrome: An Unusual Case. Am J Case Rep 2015;16:849-53. [PMID: 26621456 DOI: 10.12659/ajcr.894619] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
284 Anderson RC, Patel V, Sheikh-Bahaei N, Liu CSJ, Rajamohan AG, Shiroishi MS, Kim PE, Go JL, Lerner A, Acharya J. Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging. Front Neurol 2020;11:463. [PMID: 32612567 DOI: 10.3389/fneur.2020.00463] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
285 Miller JB, Suchdev K, Jayaprakash N, Hrabec D, Sood A, Sharma S, Levy PD. New Developments in Hypertensive Encephalopathy. Curr Hypertens Rep 2018;20:13. [PMID: 29480370 DOI: 10.1007/s11906-018-0813-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
286 Iannetti L, Zito R, Bruschi S, Papetti L, Ulgiati F, Nicita F, Del Balzo F, Spalice A. Recent understanding on diagnosis and management of central nervous system vasculitis in children. Clin Dev Immunol 2012;2012:698327. [PMID: 23008735 DOI: 10.1155/2012/698327] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
287 Kushner BH, Modak S, Basu EM, Roberts SS, Kramer K, Cheung NK. Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody. Cancer 2013;119:2789-95. [PMID: 23633099 DOI: 10.1002/cncr.28137] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
288 Graham BR, Pylypchuk GB. Posterior reversible encephalopathy syndrome in an adult patient undergoing peritoneal dialysis: a case report and literature review. BMC Nephrol 2014;15:10. [PMID: 24411012 DOI: 10.1186/1471-2369-15-10] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
289 Younes ST, Ryan MJ. Pathophysiology of Cerebral Vascular Dysfunction in Pregnancy-Induced Hypertension. Curr Hypertens Rep 2019;21:52. [PMID: 31123841 DOI: 10.1007/s11906-019-0961-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
290 Zimering JH, Mesfin A. Posterior reversible encephalopathy syndrome following elevated mean arterial pressures for cervical spinal cord injury. J Spinal Cord Med 2018;41:111-4. [PMID: 27917700 DOI: 10.1080/10790268.2016.1250030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
291 Shieh A, Darro N. Recurrent Posterior Reversible Encephalopathy Syndrome in an Adolescent Boy with End-Stage Renal Disease. Case Rep Pediatr 2021;2021:6675454. [PMID: 33643673 DOI: 10.1155/2021/6675454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
292 Waggoner J, Martinu T, Palmer SM. Progressive multifocal leukoencephalopathy following heightened immunosuppression after lung transplant. J Heart Lung Transplant 2009;28:395-8. [PMID: 19332268 DOI: 10.1016/j.healun.2008.12.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
293 Kamiya-Matsuoka C, Cachia D, Olar A, Armstrong TS, Gilbert MR. Primary brain tumors and posterior reversible encephalopathy syndrome. Neurooncol Pract 2014;1:184-90. [PMID: 26034631 DOI: 10.1093/nop/npu024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
294 Cantone M, Lanza G, Puglisi V, Vinciguerra L, Mandelli J, Fisicaro F, Pennisi M, Bella R, Ciurleo R, Bramanti A. Hypertensive Crisis in Acute Cerebrovascular Diseases Presenting at the Emergency Department: A Narrative Review. Brain Sci 2021;11:70. [PMID: 33430236 DOI: 10.3390/brainsci11010070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
295 Schoucair R, Nicolas G, Ahdab R, Bejjani N, Abdalla EK. Posterior reversible encephalopathy syndrome (PRES) in mesenteric leiomyosarcoma: A case report. Int J Surg Case Rep 2018;49:96-101. [PMID: 29980031 DOI: 10.1016/j.ijscr.2018.04.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
296 Im HJ, Koh KN, Seo JJ. Recent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescents. Blood Res 2016;51:8-16. [PMID: 27104186 DOI: 10.5045/br.2016.51.1.8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
297 Ahn CH, Han SA, Kong YH, Kim SJ. Clinical characteristics of hypertensive encephalopathy in pediatric patients. Korean J Pediatr 2017;60:266-71. [PMID: 29042869 DOI: 10.3345/kjp.2017.60.8.266] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
298 McDermott M, Miller EC, Rundek T, Hurn PD, Bushnell CD. Preeclampsia: Association With Posterior Reversible Encephalopathy Syndrome and Stroke. Stroke 2018;49:524-30. [PMID: 29438078 DOI: 10.1161/STROKEAHA.117.018416] [Cited by in Crossref: 51] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
299 Dhillon A, Velazquez C, Siva C. Rheumatologic diseases and posterior reversible encephalopathy syndrome: two case reports and review of the literature. Rheumatol Int 2012;32:3707-13. [PMID: 22825304 DOI: 10.1007/s00296-012-2476-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
300 Bartynski WS, Boardman JF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2008;29:447-455. [PMID: 18079186 DOI: 10.3174/ajnr.a0839] [Cited by in Crossref: 174] [Cited by in F6Publishing: 39] [Article Influence: 12.4] [Reference Citation Analysis]
301 Abe T, Tokuda Y. Recurrent posterior reversible encephalopathy syndrome of the brainstem in a hypertensive patient with end-stage renal disease. J Emerg Trauma Shock 2014;7:242-3. [PMID: 25114439 DOI: 10.4103/0974-2700.136876] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
302 Rostasy K, Monti L, Lipton SA, Hedreen JC, Gonzalez RG, Navia BA. HIV leucoencephalopathy and TNFalpha expression in neurones. J Neurol Neurosurg Psychiatry 2005;76:960-4. [PMID: 15965202 DOI: 10.1136/jnnp.2004.036889] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
303 Teotónio R, Marmoto D, Januário C, Bento C. Posterior reversible encephalopathy syndrome: the importance of early diagnosis. BMJ Case Rep 2012;2012:bcr2012006852. [PMID: 22987908 DOI: 10.1136/bcr-2012-006852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
304 Spencer D. PRES-ing for Answers About Long-Term Seizure Risk in Patients With Posterior Reversible Encephalopathy Syndrome. Epilepsy Curr 2015;15:317-8. [PMID: 26633947 DOI: 10.5698/1535-7511-15.6.317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
305 Nixon NA, Parhar K. Posterior reversible encephalopathy syndrome resulting from repeat bortezomib usage. BMJ Case Rep 2014;2014:bcr2014204592. [PMID: 24903728 DOI: 10.1136/bcr-2014-204592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
306 Chen S, Hu J, Xu L, Brandon D, Yu J, Zhang J. Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review. Mol Neurobiol 2016;53:6897-909. [PMID: 26666662 DOI: 10.1007/s12035-015-9560-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
307 Morrow SA, Rana R, Lee D, Paul T, Mahon JL. Posterior Reversible Encephalopathy Syndrome due to High Dose Corticosteroids for an MS Relapse. Case Rep Neurol Med 2015;2015:325657. [PMID: 26101676 DOI: 10.1155/2015/325657] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
308 Ganesh K, Nair RR, Kurian G, Mathew A, Sreedharan S, Paul Z. Posterior Reversible Encephalopathy Syndrome in Kidney Disease. Kidney Int Rep. 2018;3:502-507. [PMID: 29725657 DOI: 10.1016/j.ekir.2017.10.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
309 Capalbo D, De Martino L, Giardino G, Di Mase R, Di Donato I, Parenti G, Vajro P, Pignata C, Salerno M. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: insights into genotype-phenotype correlation. Int J Endocrinol 2012;2012:353250. [PMID: 23133448 DOI: 10.1155/2012/353250] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
310 Hwang IK, Yi SS, Shin JH, Yoo KY, Choi JH, Lee CH, Seong JK, Yoon YS, Park JH, Won MH. Cyclosporine A reduces dendritic outgrowth of neuroblasts in the subgranular zone of the dentate gyrus in C57BL/6 mice. Neurochem Res 2010;35:465-72. [PMID: 19856205 DOI: 10.1007/s11064-009-0082-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
311 Ikeda T, Asano M, Kitada Y, Taguchi K, Hayashi Y, Kajita K, Morita H. Relapsing Polychondritis with a Cobble-stone Appearance of the Tracheal Mucosa, Preceded by Posterior Reversible Encephalopathy Syndrome. Intern Med 2020;59:1093-7. [PMID: 32009099 DOI: 10.2169/internalmedicine.4095-19] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
312 Babi MA, Gorman MJ, Cipolla MJ, Allen G, Al Jerdi S, Clouser R, Commichau C. Ondansetron-related hemorrhagic posterior reversible encephalopathy syndrome (PRES) following gastric bypass. Springerplus 2016;5:18. [PMID: 26759757 DOI: 10.1186/s40064-015-1644-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
313 Hamid M, Ghani A, Micaily I, Sarwar U, Lashari B, Malik F. Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer. J Community Hosp Intern Med Perspect 2018;8:130-3. [PMID: 29915651 DOI: 10.1080/20009666.2018.1478563] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
314 Admane SS, Yelne TS, Giri PJ. A Case of Posterior Reversible Encephalopathy Syndrome Mimicking Stroke. Indian J Crit Care Med 2020;24:877-8. [PMID: 33132577 DOI: 10.5005/jp-journals-10071-23588] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Chao AS, Chen YL, Chang YL, Chao A, Su SY, Wang TH. Severe pre-eclamptic women with headache: is posterior reversible encephalopathy syndrome an associated concurrent finding? BMC Pregnancy Childbirth 2020;20:336. [PMID: 32487027 DOI: 10.1186/s12884-020-03017-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Gudkova VV, Shanina TV, Kimelfeld EI, Salimov KA, Orekhova MA, Fedotov EV, Stakhovskaya LV. [Posterior reversible encephalopathy syndrome as a presentation of acute intermittent porphyria]. Zh Nevrol Psikhiatr Im S S Korsakova 2020;120:60-6. [PMID: 32323945 DOI: 10.17116/jnevro202012003160] [Reference Citation Analysis]
317 Fabbian F, Pala M, Fallica E, Capone J, Monetti VC, Fratti D, Fainardi E. Posterior reversible encephalopathy syndrome in an 87-year-old woman with Escherichia coli bloodstream infection. Clin Exp Nephrol. 2010;14:176-179. [PMID: 19882204 DOI: 10.1007/s10157-009-0234-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
318 Lee G, Lee SE, Ryu KH, Yoo ES. Posterior reversible encephalopathy syndrome in pediatric patients undergoing treatment for hemophagocytic lymphohistiocytosis: clinical outcomes and putative risk factors. Blood Res 2013;48:258-65. [PMID: 24466550 DOI: 10.5045/br.2013.48.4.258] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
319 Chen TH, Chiou SS, Lin WC, Wang IF, Chen IC, Dai ZK, Wu JR, Hsu JH. Posterior reversible encephalopathy syndrome in critically ill children: a case series. Intensive Care Med 2013;39:155-6. [PMID: 23052954 DOI: 10.1007/s00134-012-2705-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
320 Kent M. The cat with neurological manifestations of systemic disease. Key conditions impacting on the CNS. J Feline Med Surg 2009;11:395-407. [PMID: 19389639 DOI: 10.1016/j.jfms.2009.03.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
321 Furuya M, Kurasawa K, Nagahama K, Kawachi K, Nozawa A, Takahashi T, Aoki I. Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia. J Pregnancy 2011;2011:123717. [PMID: 21490787 DOI: 10.1155/2011/123717] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
322 Agarwal S, Melmed K, Dogra S, Jain R, Conway J, Galetta S, Lewis A. Increase in Ventricle Size and the Evolution of White Matter Changes on Serial Imaging in Critically Ill Patients with COVID-19. Neurocrit Care 2021. [PMID: 33674942 DOI: 10.1007/s12028-021-01207-2] [Reference Citation Analysis]
323 Chen Z, Zhang G, Lerner A, Wang AH, Gao B, Liu J. Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis. Quant Imaging Med Surg 2018;8:421-32. [PMID: 29928607 DOI: 10.21037/qims.2018.05.07] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 7.3] [Reference Citation Analysis]
324 Hobson EV, Craven I, Blank SC. Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness. Perit Dial Int 2012;32:590-4. [PMID: 23212858 DOI: 10.3747/pdi.2012.00152] [Cited by in Crossref: 88] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
325 Kim D. Posterior reversible encephalopathy syndrome induced by nivolumab immunotherapy for non-small-cell lung cancer. Clin Case Rep 2019;7:935-8. [PMID: 31110718 DOI: 10.1002/ccr3.2122] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
326 Abenza-Abildua MJ, Fuentes B, Diaz D, Royo A, Olea T, Aguilar-Amat MJ, Diez-Tejedor E. Cyclophosphamide-induced reversible posterior leukoencephalopathy syndrome. BMJ Case Rep. 2009;2009. [PMID: 21686794 DOI: 10.1136/bcr.07.2008.0467] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
327 Pilato F, Distefano M, Calandrelli R. Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Considerations. Front Neurol 2020;11:34. [PMID: 32117007 DOI: 10.3389/fneur.2020.00034] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 20.0] [Reference Citation Analysis]
328 Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke 2009;40:1169-75. [PMID: 19211496 DOI: 10.1161/STROKEAHA.108.527788] [Cited by in Crossref: 148] [Cited by in F6Publishing: 45] [Article Influence: 12.3] [Reference Citation Analysis]
329 Saad AF, Chaudhari R, Wintermark M. Imaging of Atypical and Complicated Posterior Reversible Encephalopathy Syndrome. Front Neurol 2019;10:964. [PMID: 31551919 DOI: 10.3389/fneur.2019.00964] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 7.5] [Reference Citation Analysis]
330 Poma S, Delmonte MP, Gigliuto C, Imberti R, Delmonte M, Arossa A, Iotti GA. Management of posterior reversible syndrome in preeclamptic women. Case Rep Obstet Gynecol 2014;2014:928079. [PMID: 25506009 DOI: 10.1155/2014/928079] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
331 Hu D, Xiong J, Zha Y, Zhang Z. Posterior reversible encephalopathy syndrome complicated with subarachnoid hemorrhage in an eclamptic pregnant patient: case report. BMC Neurol 2018;18:182. [PMID: 30390663 DOI: 10.1186/s12883-018-1186-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
332 Demirel İ, Kavak BS, Özer AB, Bayar MK, Erhan ÖL. An intensive care approach to posterior reversible encephalopathy syndrome (PRES): An analysis of 7 cases. J Turk Ger Gynecol Assoc 2014;15:217-21. [PMID: 25584029 DOI: 10.5152/jtgga.2014.14072] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
333 Server A, Bargalló N, Fløisand Y, Sponheim J, Graus F, Hald JK. Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation. Neuroradiology 2017;59:105-26. [PMID: 28255902 DOI: 10.1007/s00234-017-1804-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
334 Sutter R, Chalela JA, Leigh R, Kaplan PW, Yenokyan G, Sharshar T, Stevens RD. Significance of Parenchymal Brain Damage in Patients with Critical Illness. Neurocrit Care 2015;23:243-52. [PMID: 25650012 DOI: 10.1007/s12028-015-0110-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
335 Kopcow HD, Karumanchi SA. Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia. J Reprod Immunol 2007;76:23-9. [PMID: 17490755 DOI: 10.1016/j.jri.2007.03.018] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
336 Marra AM, Barilaro G, Villella V, Granata M. Eosinophilic granulomatosis with polyangiitis (EGPA) and PRES: a case-based review of literature in ANCA-associated vasculitides. Rheumatol Int. 2015;35:1591-1595. [PMID: 25836767 DOI: 10.1007/s00296-015-3261-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
337 Raman MR, Tosakulwong N, Zuk SM, Senjem ML, White WM, Fields JA, Mielke MM, Lesnick TG, Bailey KR, Jack CR Jr, Miller VM, Garovic VD, Kantarci K. Influence of preeclampsia and late-life hypertension on MRI measures of cortical atrophy. J Hypertens 2017;35:2479-85. [PMID: 28800041 DOI: 10.1097/HJH.0000000000001492] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
338 Sperling RA, Jack CR Jr, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, Black RS, Brashear HR, Grundman M, Siemers ER, Feldman HH, Schindler RJ. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement 2011;7:367-85. [PMID: 21784348 DOI: 10.1016/j.jalz.2011.05.2351] [Cited by in Crossref: 295] [Cited by in F6Publishing: 251] [Article Influence: 29.5] [Reference Citation Analysis]
339 Murthy JM, Jaiswal SK, Gaade KA. Posterior Reversible Encephalopathy Syndrome Is the Common Cause of New-Onset Seizures in the Peripartum Period: A Tertiary Hospital-Based Study in South India. J Epilepsy Res 2021;11:49-55. [PMID: 34395223 DOI: 10.14581/jer.21007] [Reference Citation Analysis]
340 Moser M, Brown CM, Rose CH, Garovic VD. Hypertension in pregnancy: is it time for a new approach to treatment? J Hypertens 2012;30:1092-100. [PMID: 22573074 DOI: 10.1097/HJH.0b013e3283536319] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 3.6] [Reference Citation Analysis]
341 Cordelli DM, Masetti R, Zama D, Toni F, Castelli I, Ricci E, Franzoni E, Pession A. Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation. Front Pediatr. 2017;5:105. [PMID: 28555178 DOI: 10.3389/fped.2017.00105] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
342 Kim SM, Choi H, Kim Y, Shin J, Jang HR, Lee JE, Huh W, Kim DJ, Oh HY, Kim YG. Posterior Reversible Encephalopathy Syndrome during Recovery from Acute Kidney Injury after Hepatitis A Infection. Case Rep Nephrol Urol 2012;2:33-7. [PMID: 23197953 DOI: 10.1159/000339253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
343 Legriel S, Merceron S, Pico F, Cordoliani YS, Bedos JP. A rare cause of status epilepticus. Intensive Care Med 2011;37:1718-9. [PMID: 21755395 DOI: 10.1007/s00134-011-2310-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
344 Zappia F, Verzicco I, Simoni R, Ferrari M, Coghi P, Bozzetti F, Cannone V, Volpi R, Cabassi A. Posterior reversible encephalopathy syndrome in an oncological normotensive patient: evidence for a pathogenic role of concomitant low magnesium serum levels and chemotherapy treatment. Acta Biomed 2020;91:365-72. [PMID: 32420975 DOI: 10.23750/abm.v91i2.8685] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
345 Pathireddy S, Bose S, Baradhi K, Aeddula NR. Rare but not beyond care: a young female with altered mental status and seizures. Oxf Med Case Reports 2019;2019:omz072. [PMID: 31398723 DOI: 10.1093/omcr/omz072] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
346 Gokce M, Dogan E, Nacitarhan S, Demirpolat G. Posterior reversible encephalopathy syndrome caused by hypertensive encephalopathy and acute uremia. Neurocrit Care 2006;4:133-6. [PMID: 16627901 DOI: 10.1385/NCC:4:2:133] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
347 Claveau JS, LeBlanc R, Ahmad I, Ferreira J, Pistono AA, Bambace N, Bernard L, Cohen S, Delisle JS, Kiss T, Lachance S, Roy J. Cerebral adenovirus endotheliitis presenting as posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation. Bone Marrow Transplant 2017;52:1457-9. [PMID: 28692025 DOI: 10.1038/bmt.2017.154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]